RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Liver Cirrhosis
Accession: DOID:9001573
browse the term
Definition: Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
Synonyms: exact_synonym: Experimental Hepatic Cirrhosis; Experimental Hepatic Fibrosis; Experimental Liver Cirrhoses
primary_id: MESH:D008106
alt_id: RDO:0006022
G
A2M
alpha-2-macroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:62,406,928...62,483,690
Ensembl chr 5:62,440,810...62,483,678
G
AADAT
aminoadipate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:19,768,816...19,792,254
Ensembl chr14:19,768,776...19,792,256
G
ABAT
4-aminobutyrate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:33,913,068...33,960,804
Ensembl chr 3:33,908,970...34,015,474
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16182555 PMID:17072980
NCBI chr 9:93,049,955...93,146,469
G
ABCC2
ATP binding cassette subfamily C member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,582...111,038,898
G
ABCC5
ATP binding cassette subfamily C member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:121,868,614...121,957,901
Ensembl chr13:121,869,600...121,926,071
G
ABCG1
ATP binding cassette subfamily G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:205,561,897...205,628,428
Ensembl chr13:205,561,951...205,628,425
G
ABCG5
ATP binding cassette subfamily G member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:96,616,304...96,656,893
Ensembl chr 3:96,616,246...96,656,889
G
ABCG8
ATP binding cassette subfamily G member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:96,596,975...96,616,224
Ensembl chr 3:96,596,531...96,616,229
G
ABLIM3
actin binding LIM protein family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:150,260,185...150,423,214
Ensembl chr 2:150,260,196...150,423,212
G
ACAT1
acetyl-CoA acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:36,525,266...36,545,634
Ensembl chr 9:36,525,261...36,545,633
G
ACBD4
acyl-CoA binding domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:18,271,835...18,281,639
Ensembl chr12:18,272,797...18,281,595
G
ACE
angiotensin I converting enzyme
severity
ISO
protein:increased activity:plasma (human) mRNA:increased expression:liver (rat) mRNA: increased expression:liver (rat)
RGD
PMID:8445218 PMID:19424597 PMID:23663763 PMID:24035938
RGD:21408579 RGD:25671449 RGD:25671457 RGD:25671458
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACE2
angiotensin converting enzyme 2
ISO
protein:increased expression:liver mRNA, protein:increased expression, increased activity:liver (rat)
RGD
PMID:16166274 PMID:19793108
RGD:2316776 RGD:40818265
NCBI chr X:12,099,849...12,152,204
Ensembl chr X:12,093,242...12,151,286
G
ACHE
acetylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16496349
NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
G
ACKR3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:136,370,457...136,382,559
Ensembl chr15:136,370,530...136,382,553
G
ACOT9
acyl-CoA thioesterase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:19,835,674...19,864,570
Ensembl chr X:19,834,614...19,864,660
G
ACOX2
acyl-CoA oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:40,220,952...40,255,967
Ensembl chr13:40,223,010...40,255,967
G
ACP5
acid phosphatase 5, tartrate resistant
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:70,206,159...70,209,855
Ensembl chr 2:70,206,162...70,208,229
G
ACSL1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:45,866,858...45,936,327
Ensembl chr15:45,866,857...45,963,729
G
ACTA2
actin alpha 2, smooth muscle
ISO
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)
CTD RGD
PMID:26435214 PMID:26739621 PMID:29323718
RGD:38599216
NCBI chr14:100,868,145...100,886,732
Ensembl chr14:100,867,733...100,886,713
G
ACTN1
actinin alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:92,550,132...92,644,842
Ensembl chr 7:92,550,007...92,644,842
G
ACVR2A
activin A receptor type 2A
ISO
mRNA:decreased expression:liver
RGD
PMID:12706302
RGD:2325237
NCBI chr15:4,177,333...4,259,056
Ensembl chr15:4,173,805...4,259,706
G
ADA
adenosine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
G
ADAM17
ADAM metallopeptidase domain 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:126,795,513...126,853,995
Ensembl chr 3:126,795,426...126,853,995
G
ADD3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:120,451,421...120,583,725
Ensembl chr14:120,451,575...120,583,722
G
ADGRE1
adhesion G protein-coupled receptor E1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:72,217,036...72,305,925
G
ADH4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 8:121,225,485...121,259,262 NCBI chr X:98,582,002...98,583,002
Ensembl chr 8:121,225,656...121,261,746
G
ADHFE1
alcohol dehydrogenase iron containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:68,251,970...68,285,436
Ensembl chr 4:68,250,646...68,285,405
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14724832
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADIPOR2
adiponectin receptor 2
severity
ISO
RGD
PMID:29237572
RGD:24922203
NCBI chr 5:68,755,789...68,807,247
Ensembl chr 5:68,755,811...68,807,235
G
ADM
adrenomedullin
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma
CTD RGD
PMID:15370692 PMID:16610064 PMID:16713642
RGD:1625319
NCBI chr 2:49,229,223...49,231,521
Ensembl chr 2:49,229,223...49,231,866
G
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16783407
NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
G
ADORA3
adenosine A3 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:108,854,300...108,857,769
Ensembl chr 4:108,854,357...108,873,925
G
ADRA1B
adrenoceptor alpha 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:63,550,123...64,010,838
Ensembl chr16:63,550,130...63,603,034
G
ADRB1
adrenoceptor beta 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:19785950
RGD:5129118
NCBI chr14:124,400,330...124,401,739
Ensembl chr14:124,400,330...124,401,739
G
ADRB2
adrenoceptor beta 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:19785950
RGD:5129118
NCBI chr 2:150,032,649...150,035,591
Ensembl chr 2:150,033,579...150,040,731
G
ADRB3
adrenoceptor beta 3
ISO
mRNA, protein:increased expression:liver
RGD
PMID:19785950
RGD:5129118
NCBI chr15:48,468,803...48,478,370
Ensembl chr15:48,475,144...48,479,562
G
AEN
apoptosis enhancing nuclease
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:191,200,625...191,211,884
Ensembl chr 1:191,200,632...191,219,961
G
AFM
afamin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:69,706,823...69,728,269
Ensembl chr 8:69,706,896...69,728,255
G
AFP
alpha fetoprotein
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17072980 PMID:30346985
RGD:151665755
NCBI chr 8:69,677,690...69,698,864
Ensembl chr 8:69,677,690...69,698,864
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
RGD
PMID:26522143
RGD:597538456
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
AGFG1
ArfGAP with FG repeats 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:128,898,806...128,980,782
Ensembl chr15:128,898,705...128,975,510
G
AGL
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:118,186,031...118,269,106
Ensembl chr 4:118,177,377...118,269,101
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12667390
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
G
AGTR1
angiotensin II receptor type 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12890498 PMID:24619965 PMID:25380136
RGD:10403061
NCBI chr13:88,934,873...88,980,317
Ensembl chr13:88,934,868...88,983,105
G
AHNAK
AHNAK nucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:9,186,984...9,216,450
Ensembl chr 2:9,183,862...9,287,455
G
AIDA
axin interactor, dorsalization associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:11,430,758...11,466,849
Ensembl chr10:11,428,399...11,466,643
G
AIF1
allograft inflammatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:23,711,752...23,731,191
Ensembl chr 7:23,728,726...23,731,675
G
AKR1B1
aldo-keto reductase family 1 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:14,593,516...14,752,316
Ensembl chr18:14,684,036...14,752,310
G
AKR1C1
aldo-keto reductase family 1, member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:65,580,297...65,594,998
Ensembl chr10:65,576,464...65,678,248
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:increased phosphorylation:liver
RGD
PMID:31671832
RGD:407987423
G
AKTIP
AKT interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:31,706,253...31,757,878
Ensembl chr 6:31,747,606...31,758,279
G
ALB
albumin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16642209 PMID:17963606 PMID:21163135 PMID:30346985
RGD:151665755
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 1:226,163,347...226,217,342
Ensembl chr 1:226,161,299...226,217,308
G
ALDH1B1
aldehyde dehydrogenase 1 family member B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968 PMID:25380136
NCBI chr 1:239,109,814...239,114,736
Ensembl chr 1:239,109,809...239,114,730
G
ALDH1L1
aldehyde dehydrogenase 1 family member L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr 7:53,748,585...53,794,777
Ensembl chr 7:53,748,653...53,794,706
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:79,492,672...79,558,702
Ensembl chr 5:79,492,732...79,558,701
G
ALDH2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15650968
NCBI chr14:39,902,317...39,933,113
Ensembl chr14:39,896,565...39,933,124
G
AMACR
alpha-methylacyl-CoA racemase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr16:20,005,741...20,023,339
Ensembl chr16:19,956,366...20,023,289
G
ANGPT1
angiopoietin 1
disease_progression
ISO
protein:increased expression:liver
RGD
PMID:17935226
RGD:1643338
NCBI chr 4:29,925,203...30,233,434
Ensembl chr 4:29,933,135...30,233,960
G
ANGPT2
angiopoietin 2
ISO
mRNA, protein:increased expression:multiple organs (rat)
RGD
PMID:18978178
RGD:2314174
NCBI chr15:37,544,177...37,600,925
Ensembl chr15:37,544,707...37,599,041
G
ANGPTL3
angiopoietin like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:149,836,417...149,845,854
Ensembl chr 6:149,832,542...149,845,831
G
ANO6
anoctamin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:76,112,428...76,337,073
Ensembl chr 5:76,113,212...76,356,544
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
treatment
ISO
RGD
PMID:19054144
RGD:10401133
NCBI chr 1:166,664,251...166,703,814
G
ANXA1
annexin A1
ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8755646 PMID:25380136
RGD:2306954
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059
G
ANXA3
annexin A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:73,970,314...73,993,039
G
ANXA4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:72,623,311...72,654,591
Ensembl chr 3:72,622,358...72,694,212
G
ANXA5
annexin A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:102,387,833...102,420,868
Ensembl chr 8:102,388,103...102,425,750
G
AP1S2
adaptor related protein complex 1 subunit sigma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:12,367,785...12,397,672
Ensembl chr X:12,367,795...12,397,677
G
AP3S1
adaptor related protein complex 3 subunit sigma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:119,965,539...120,039,948
Ensembl chr 2:119,965,539...120,039,947
G
APAF1
apoptotic peptidase activating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:85,166,616...85,258,751
Ensembl chr 5:85,166,628...85,258,364
G
APBB1IP
amyloid beta precursor protein binding family B member 1 interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:49,125,074...49,242,864
Ensembl chr10:49,124,543...49,189,308
G
APMAP
adipocyte plasma membrane associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:30,768,485...30,795,002
Ensembl chr17:30,768,488...30,795,755
G
APOA1
apolipoprotein A1
ISO
RGD
PMID:2123716
RGD:1599161
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
APOA4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
APOBEC1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:62,811,819...62,820,532
Ensembl chr 5:62,810,879...62,820,173
G
APP
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,435,094...189,716,056
G
APPL1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:39,089,157...39,124,969
Ensembl chr13:39,089,077...39,129,781
G
AQP7
aquaporin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr10:33,098,746...33,130,245
G
ARG1
arginase 1
ISO
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:11931836
RGD:1626298
NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
G
ARG2
arginase 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:11931836
RGD:1626298
NCBI chr 7:91,343,987...91,385,911
Ensembl chr 7:91,343,988...91,385,909
G
ARHGAP30
Rho GTPase activating protein 30
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:89,375,486...89,394,190
Ensembl chr 4:89,375,526...89,394,244
G
ARHGAP9
Rho GTPase activating protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:22,747,346...22,762,179
Ensembl chr 5:22,747,339...22,762,049
G
ARHGDIB
Rho GDP dissociation inhibitor beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:57,576,754...57,598,395
Ensembl chr 5:57,576,776...57,598,869
G
ARL11
ARF like GTPase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:18,097,723...18,100,425
Ensembl chr11:18,095,974...18,099,819
G
ARL8A
ADP ribosylation factor like GTPase 8A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:24,314,929...24,324,225
Ensembl chr10:24,314,932...24,324,228
G
ARMCX1
armadillo repeat containing X-linked 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:83,132,775...83,136,924
Ensembl chr X:83,132,792...83,136,917
G
ARPC1B
actin related protein 2/3 complex subunit 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:6,329,737...6,342,641
Ensembl chr 3:6,220,939...6,342,637
G
ARRB2
arrestin beta 2
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:aorta
CTD RGD
PMID:17256744 PMID:25380136
RGD:1625784
NCBI chr12:52,161,776...52,170,362
Ensembl chr12:52,161,778...52,170,342
G
ASAH1
N-acylsphingosine amidohydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:5,712,048...5,749,811
Ensembl chr17:5,712,058...5,758,821
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:77,318,341...77,336,290
Ensembl chr 9:77,318,213...77,343,035
G
ASPN
asporin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:42,165,553...42,192,902
Ensembl chr 3:42,165,561...42,192,813
G
ASS1
argininosuccinate synthase 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:19914391
RGD:4140452
NCBI chr 1:270,531,434...270,586,364
Ensembl chr 1:270,531,589...270,586,364
G
ATF3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:130,772,259...130,829,678
Ensembl chr 9:130,772,262...130,785,506
G
ATP10D
ATPase phospholipid transporting 10D (putative)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:37,407,677...37,531,707
Ensembl chr 8:37,407,711...37,530,373
G
ATP6V1D
ATPase H+ transporting V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:91,065,998...91,084,908
Ensembl chr 7:91,064,396...91,084,913
G
ATRN
attractin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:32,054,240...32,239,576
Ensembl chr17:32,054,249...32,239,519
G
AXL
AXL receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914
G
B2M
beta-2-microglobulin
ISO
protein:increased expression:urine
RGD
PMID:18777138
RGD:6482712
NCBI chr 1:126,837,721...126,844,043
Ensembl chr 1:126,835,143...126,981,582
G
B4GALT5
beta-1,4-galactosyltransferase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:51,257,273...51,334,566
Ensembl chr17:51,259,813...51,334,020
G
B9D1
B9 domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:60,162,656...60,171,586
Ensembl chr12:60,162,713...60,171,961
G
BAK1
BCL2 antagonist/killer 1
ISO
mRNA:increased expression:liver
RGD
PMID:11232245
RGD:2315709
NCBI chr 7:29,808,849...29,815,345
Ensembl chr 7:29,808,849...29,815,318
G
BBOX1
gamma-butyrobetaine hydroxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:33,227,965...33,296,013
Ensembl chr 2:33,227,974...33,296,559
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:17938867 PMID:24218972
RGD:10054116 RGD:2293129
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BCR
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
G
BDH1
3-hydroxybutyrate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr13:132,602,372...132,647,271
Ensembl chr13:132,605,489...132,645,937
G
BGN
biglycan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:124,282,048...124,295,450
Ensembl chr X:124,275,305...124,295,445
G
BICD2
BICD cargo adaptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:42,393,270...42,456,821
Ensembl chr 3:42,393,277...42,456,782
G
BIRC3
baculoviral IAP repeat containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,002,734...33,020,242
G
BIRC5
baculoviral IAP repeat containing 5
ISO
RGD
PMID:17938867
RGD:2293129
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BLOC1S2
biogenesis of lysosomal organelles complex 1 subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:111,391,083...111,397,609
Ensembl chr14:111,391,089...111,397,639
G
BLVRA
biliverdin reductase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:51,131,576...51,185,493
Ensembl chr18:51,131,584...51,185,435
G
BMF
Bcl2 modifying factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:131,178,021...131,199,668
Ensembl chr 1:131,178,315...131,200,393
G
BMP4
bone morphogenetic protein 4
ISO
mRNA, protein:increased expression:liver
RGD
PMID:16447265
RGD:1643229
NCBI chr 1:183,415,989...183,422,888
Ensembl chr 1:183,416,146...183,422,637
G
BMP7
bone morphogenetic protein 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17127702
NCBI chr17:57,567,770...57,676,516
Ensembl chr17:57,584,956...57,675,986
G
C13H3orf70
chromosome 13 C3orf70 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:122,958,339...123,058,988
Ensembl chr13:122,958,347...123,058,655
G
C1QA
complement C1q A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:80,586,259...80,589,213
Ensembl chr 6:80,586,280...80,589,204
G
C1QB
complement C1q B chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:80,601,680...80,606,076
Ensembl chr 6:80,601,665...80,607,471
G
C1QC
complement C1q C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:80,592,591...80,597,464
Ensembl chr 6:80,592,473...80,597,452
G
C5AR1
complement C5a receptor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15995705 PMID:25380136
RGD:1600592
NCBI chr 6:53,097,162...53,111,563
Ensembl chr 6:53,097,142...53,111,565
G
C6H1orf210
chromosome 6 C1orf210 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:167,959,845...167,963,610
Ensembl chr 6:167,960,095...167,963,583
G
C7
complement C7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:25,846,860...25,902,707
Ensembl chr16:25,846,860...25,903,980
G
C8G
complement C8 gamma chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
C9H11orf54
chromosome 9 C11orf54 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:26,167,341...26,187,627
Ensembl chr 9:26,170,413...26,187,619
G
C9H1orf21
chromosome 9 C1orf21 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:125,613,082...125,846,002
Ensembl chr 9:125,613,193...125,844,228
G
CA3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 4:51,227,485...51,237,861
Ensembl chr 4:51,227,485...51,237,844
G
CA5A
carbonic anhydrase 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:1,495,615...1,539,390
Ensembl chr 6:1,506,042...1,538,777
G
CAMK2D
calcium/calmodulin dependent protein kinase II delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:108,916,019...109,221,317
Ensembl chr 8:108,915,572...109,222,905
G
CAPG
capping actin protein, gelsolin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:59,335,483...59,366,855
Ensembl chr 3:59,339,966...59,366,846
G
CASP1
caspase 1, apoptosis-related cysteine peptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
G
CASP7
caspase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
G
CAV1
caveolin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
G
CCDC126
coiled-coil domain containing 126
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:92,372,070...92,419,241
Ensembl chr 9:92,372,072...92,419,236
G
CCL2
chemokine (C-C motif) ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15492853 PMID:19144177 PMID:28437891
RGD:14995945 RGD:2307001 RGD:8549576
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCL5
C-C motif chemokine ligand 5
treatment severity disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver
RGD CTD
PMID:20978355 PMID:22574195 PMID:25380136 PMID:25617348
RGD:14995328 RGD:14995329 RGD:14995337
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCN2
cellular communication network factor 2
ISO
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19856102 PMID:25380136
RGD:2314367
NCBI chr 1:31,674,398...31,677,697
Ensembl chr 1:31,674,394...31,677,691
G
CCN4
cellular communication network factor 4
ISO
RGD
PMID:24600972
RGD:10003105
NCBI chr 4:8,078,163...8,110,906
Ensembl chr 4:8,079,755...8,110,700
G
CCNA2
cyclin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:102,260,346...102,266,274
Ensembl chr 8:102,260,215...102,266,309
G
CCNB2
cyclin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:112,907,047...112,942,218
Ensembl chr 1:112,907,047...112,942,235
G
CCNG1
cyclin G1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:60,349,255...60,356,737
Ensembl chr16:60,349,258...60,356,738
G
CCR5
C-C motif chemokine receptor 5
treatment
ISO
mRNA,protein:increased expression:liver
RGD
PMID:19603542
RGD:14401743
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CD163
CD163 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:63,300,200...63,334,497
Ensembl chr 5:63,300,231...63,334,498
G
CD200R1
CD200 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:146,953,135...146,994,325
Ensembl chr13:146,953,149...146,995,323
G
CD276
CD276 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:59,703,283...59,733,910
Ensembl chr 7:59,703,289...59,733,777
G
CD36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
CD38
CD38 molecule
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16343077 PMID:25380136
RGD:2307239
NCBI chr 8:11,083,682...11,130,783
Ensembl chr 8:11,083,682...11,130,756
G
CD48
CD48 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:89,828,923...89,844,471
Ensembl chr 4:89,828,923...89,844,484
G
CD53
CD53 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:109,306,552...109,335,876
Ensembl chr 4:109,306,555...109,335,802
G
CD5L
CD5 molecule like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:92,394,535...92,412,146
G
CD63
CD63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:21,172,275...21,176,225
Ensembl chr 5:21,172,283...21,176,232
G
CD68
CD68 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:52,874,754...52,877,256
Ensembl chr12:52,874,785...52,877,695
G
CD7
CD7 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:740,345...744,876
G
CD74
CD74 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:151,402,210...151,409,924
Ensembl chr 2:151,402,211...151,409,833
G
CD83
CD83 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:10,346,122...10,385,968
Ensembl chr 7:10,359,211...10,385,961
G
CD86
CD86 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
G
CDC42SE1
CDC42 small effector 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:98,171,937...98,180,577
Ensembl chr 4:98,164,024...98,180,576
G
CDH1
cadherin 1
ISO
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDH5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:27,108,560...27,142,145
Ensembl chr 6:27,108,597...27,142,177
G
CDK1
cyclin dependent kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:64,233,945...64,255,290
Ensembl chr14:64,233,987...64,372,197
G
CDK2
cyclin dependent kinase 2
ISO
RGD
PMID:16534847
RGD:2289284
NCBI chr 5:21,365,723...21,372,170
Ensembl chr 5:21,365,764...21,372,168
G
CDK4
cyclin dependent kinase 4
ISO
RGD
PMID:16534847
RGD:2289284
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,354,672...32,363,761
G
CDKN2AIPNL
CDKN2A interacting protein N-terminal like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:136,678,015...136,685,901
Ensembl chr 2:136,677,034...136,685,955
G
CDKN3
cyclin dependent kinase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:183,792,606...183,809,178
Ensembl chr 1:183,792,688...183,809,174
G
CDO1
cysteine dioxygenase type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 2:119,927,768...119,940,690
Ensembl chr 2:119,927,772...119,940,665
G
CEBPD
CCAAT enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:79,872,863...79,874,481
Ensembl chr 4:79,872,939...79,874,477
G
CELA1
chymotrypsin like elastase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
G
CELF2
CUGBP Elav-like family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:60,504,925...60,867,631
Ensembl chr10:60,506,504...61,084,960
G
CEMIP2
cell migration inducing hyaluronidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:224,960,875...225,042,378
Ensembl chr 1:224,960,875...225,042,308
G
CERK
ceramide kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:2,818,738...2,870,200
Ensembl chr 5:2,818,784...2,870,195
G
CES3
carboxylesterase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 6:27,627,712...27,637,827
Ensembl chr 6:27,627,742...27,638,760
G
CFD
complement factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:77,509,792...77,511,988
Ensembl chr 2:77,509,795...77,511,974
G
CFP
complement factor properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:42,145,754...42,152,879
Ensembl chr X:42,143,697...42,152,868
G
CHSY1
chondroitin sulfate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:139,730,703...139,804,458
Ensembl chr 1:139,730,721...139,804,657
G
CIDEA
cell death inducing DFFA like effector a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:97,253,074...97,268,355
Ensembl chr 6:97,253,074...97,267,405
G
CKLF
chemokine like factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:27,258,392...27,267,701
Ensembl chr 6:27,258,551...27,267,753
G
CLEC4F
C-type lectin domain family 4 member F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:71,683,898...71,696,357
Ensembl chr 3:71,677,918...71,696,346
G
CLIC1
chloride intracellular channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:23,842,829...23,851,162
G
CLIC2
chloride intracellular channel 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:125,546,451...125,560,059
Ensembl chr X:125,546,467...125,570,523
G
CLP1
cleavage factor polyribonucleotide kinase subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:13,282,157...13,285,208
Ensembl chr 2:13,282,164...13,285,162
G
CMTM3
CKLF like MARVEL transmembrane domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:27,308,146...27,320,449
Ensembl chr 6:27,308,141...27,317,308
G
CNDP1
carnosine dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:149,523,983...149,564,728
Ensembl chr 1:149,521,510...149,562,623
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:20,758,081...20,765,655
Ensembl chr12:20,758,083...20,765,553
G
CNPY4
canopy FGF signaling regulator 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:8,026,997...8,031,685
Ensembl chr 3:8,027,054...8,031,927
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043671
NCBI chr 1:56,466,022...56,493,275
Ensembl chr 1:56,467,835...56,492,602
G
COL12A1
collagen type XII alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:90,744,409...90,875,127
Ensembl chr 1:90,744,612...90,875,118
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (rat)
CTD RGD
PMID:16009107 PMID:20818932 PMID:22706148 PMID:23958495 PMID:25380136 PMID:26435214 PMID:26739621 PMID:30346985 More...
RGD:151665755 RGD:1601595 RGD:5688339 RGD:8552710 RGD:8552768
NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,004
G
COL1A2
collagen type I alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7512265 PMID:25380136
RGD:7257544
NCBI chr 9:74,174,484...74,210,407
Ensembl chr 9:74,173,931...74,210,397
G
COL3A1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11788567 PMID:25380136
NCBI chr15:93,556,914...93,595,678
Ensembl chr15:93,526,603...93,596,363
G
COL4A1
collagen type IV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:76,858,332...76,997,409
Ensembl chr11:76,858,356...76,997,322
G
COL4A2
collagen type IV alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:76,996,885...77,161,617
Ensembl chr11:76,997,516...77,161,614
G
COL5A1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:273,934,219...274,083,264
Ensembl chr 1:273,971,971...274,085,111
G
COL5A2
collagen type V alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:93,611,856...93,981,131
Ensembl chr15:93,611,856...93,800,191
G
COL6A2
collagen type VI alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism Protein:increased expression:liver
CTD RGD
PMID:7791542 PMID:25380136
RGD:1600938
G
COLEC12
collectin subfamily member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:105,808,157...106,000,197
Ensembl chr 6:105,808,221...106,007,730
G
COQ10A
coenzyme Q10A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:21,665,252...21,670,323
Ensembl chr 5:21,665,252...21,669,045
G
COTL1
coactosin like F-actin binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:4,099,341...4,146,281
Ensembl chr 6:4,099,414...4,147,469
G
CPQ
carboxypeptidase Q
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:39,492,663...39,855,959
Ensembl chr 4:39,480,676...39,967,629
G
CPS1
carbamoyl-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver
CTD RGD
PMID:15650968 PMID:17539997
RGD:2303515
NCBI chr15:113,210,038...113,339,086
Ensembl chr15:113,150,157...113,339,078
G
CRADD
CASP2 and RIPK1 domain containing adaptor with death domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:89,257,603...89,480,414
Ensembl chr 5:89,267,944...89,479,712
G
CREB1
cAMP responsive element binding protein 1
ISO
associated with Chemical and Drug Induced Liver Injury
RGD
PMID:27279449
RGD:401960093
NCBI chr15:110,705,548...110,773,037
Ensembl chr15:110,705,496...110,771,728
G
CROT
carnitine O-octanoyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:93,263,606...93,308,150
Ensembl chr 9:93,258,619...93,308,151
G
CRP
C-reactive protein, pentraxin-related
ISO
protein:decreased expression:serum:
RGD
PMID:21806828
RGD:9491781
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
CRTAP
cartilage associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:18,994,371...19,040,297
Ensembl chr13:18,995,234...19,035,720
G
CRY1
cryptochrome circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:13,275,265...13,429,566
Ensembl chr 5:13,275,545...13,364,593
G
CRYAB
crystallin alpha B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:39,638,505...39,643,530
Ensembl chr 9:39,638,506...39,643,530
G
CSAD
cysteine sulfinic acid decarboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 5:18,379,340...18,410,446
Ensembl chr 5:18,379,288...18,410,646
G
CSF1R
colony stimulating factor 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSF3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15661404
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
G
CSGALNACT1
chondroitin sulfate N-acetylgalactosaminyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:12,145,141...12,498,777
Ensembl chr17:12,428,893...12,498,585
G
CTSS
cathepsin S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:98,415,273...98,442,952
Ensembl chr 4:98,417,883...98,442,950
G
CTSZ
cathepsin Z
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:59,141,497...59,149,377
Ensembl chr17:59,138,621...59,149,377
G
CTTNBP2NL
CTTNBP2 N-terminal like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:107,957,420...108,012,764
Ensembl chr 4:107,959,571...108,011,611
G
CXADR
CXADR Ig-like cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:182,134,416...182,185,977
Ensembl chr13:182,134,566...182,185,950
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752
G
CXCL13
C-X-C motif chemokine ligand 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:73,071,261...73,077,342
G
CXCL16
C-X-C motif chemokine ligand 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:52,145,100...52,150,267
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
G
CYBA
cytochrome b-245 alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:1,015,212...1,021,422
Ensembl chr 6:1,015,162...1,021,420
G
CYBB
cytochrome b-245 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:33,654,656...33,678,346
Ensembl chr X:33,643,648...33,680,580
G
CYGB
cytoglobin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16581302
NCBI chr12:4,977,245...4,988,283
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr14:113,805,616...113,820,445
Ensembl chr14:113,805,611...113,812,041
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
G
CYP26A1
cytochrome P450 family 26 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:104,561,394...104,567,099
Ensembl chr14:104,563,195...104,567,095
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:6,539,021...6,543,643
Ensembl chr 5:6,538,907...6,543,642
G
CYP3A22
cytochrome P450 family 3 subfamily A member 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:6,617,256...6,665,179
Ensembl chr 3:6,615,343...6,822,817
G
CYP3A29
cytochrome P450 family 3 subfamily A member 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 3:6,738,502...6,778,121
Ensembl chr 3:6,738,486...6,778,944
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
treatment
ISO
RGD
PMID:15521018
RGD:15045602
NCBI chr 4:74,343,101...74,372,628
Ensembl chr 4:74,343,123...74,372,621
G
CYRIA
CYFIP related Rac1 interactor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:120,968,016...121,069,372
Ensembl chr 3:120,968,060...121,069,240
G
CYRIB
CYFIP related Rac1 interactor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:10,476,137...10,643,395
G
CYSTM1
cysteine rich transmembrane module containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:141,945,032...142,010,239
Ensembl chr 2:141,954,092...141,992,368
G
DAG1
dystroglycan 1
ISO
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr13:32,028,019...32,092,450
Ensembl chr13:32,029,522...32,092,450
G
DAO
D-amino acid oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:41,931,549...41,950,628
Ensembl chr14:41,931,541...41,950,633
G
DBH
dopamine beta-hydroxylase
ISO
mRNA:decreased expression:superior mesenteric artery (rat)
RGD
PMID:18457899
RGD:5129683
NCBI chr 1:273,204,407...273,225,562
Ensembl chr 1:273,204,175...273,225,552
G
DBNDD2
dysbindin domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:47,686,220...47,729,663
Ensembl chr17:47,725,132...47,729,668
G
DCXR
dicarbonyl and L-xylulose reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:978,131...980,042
Ensembl chr12:978,139...982,259
G
DDC
dopa decarboxylase
ISO
mRNA:decreased expression:superior mesenteric artery (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18457899 PMID:25380136
RGD:5129683
NCBI chr 9:136,496,364...136,571,220
Ensembl chr 9:136,496,365...136,571,212
G
DEPDC7
DEP domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:27,909,282...27,928,859
Ensembl chr 2:27,909,285...27,928,820
G
DHRS3
dehydrogenase/reductase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:72,556,234...72,599,233
Ensembl chr 6:72,556,236...72,598,815
G
DHRS7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:189,153,579...189,170,745
Ensembl chr 1:189,151,131...189,170,534
G
DHTKD1
dehydrogenase E1 and transketolase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:59,820,418...59,875,322
Ensembl chr10:59,820,423...59,875,290
G
DIO1
iodothyronine deiodinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 6:158,376,744...158,392,745
Ensembl chr 6:158,375,602...158,392,754
G
DIPK2A
divergent protein kinase domain 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:84,634,716...84,656,112
Ensembl chr13:84,634,777...84,657,371
G
DOCK10
dedicator of cytokinesis 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:126,435,577...126,711,755
Ensembl chr15:126,435,579...126,711,531
G
DOCK7
dedicator of cytokinesis 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:149,745,375...149,971,853
Ensembl chr 6:149,748,036...149,972,168
G
DPP7
dipeptidyl peptidase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
DPYS
dihydropyrimidinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:32,791,152...32,879,489
Ensembl chr 4:32,789,460...32,879,489
G
DRAM1
DNA damage regulated autophagy modulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:82,292,578...82,325,580
Ensembl chr 5:82,290,385...82,325,562
G
DUS1L
dihydrouridine synthase 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:945,459...951,720
Ensembl chr12:946,048...951,776
G
DUSP16
dual specificity phosphatase 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:59,869,902...59,961,839
Ensembl chr 5:59,915,197...59,961,829
G
DUSP6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:93,303,058...93,307,510
Ensembl chr 5:93,302,975...93,307,504
G
DYSF
dysferlin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:71,020,143...71,237,658
Ensembl chr 3:71,020,144...71,246,967
G
ECE1
endothelin converting enzyme 1
ISO
protein:increased expression:liver
RGD
PMID:16170464
RGD:7243952
NCBI chr 6:79,408,322...79,465,827
Ensembl chr 6:79,408,326...79,466,152
G
ECT2
epithelial cell transforming 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:111,248,215...111,310,746
Ensembl chr13:111,248,131...111,314,828
G
EDN1
endothelin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12609069
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
EEIG2
EEIG family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:111,391,672...111,467,230
Ensembl chr 4:111,392,338...111,467,300
G
EGF
epidermal growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046
G
EIF4E3
eukaryotic translation initiation factor 4E family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:53,080,200...53,152,335
Ensembl chr13:53,083,645...53,124,240
G
ELOVL5
ELOVL fatty acid elongase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:46,860,768...46,932,945
Ensembl chr 7:46,860,770...46,932,926
G
EMB
embigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:30,121,072...30,170,495
Ensembl chr16:30,120,493...30,287,793
G
EMP1
epithelial membrane protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:59,245,317...59,267,466
Ensembl chr 5:59,244,691...59,268,025
G
ENC1
ectodermal-neural cortex 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:83,678,518...83,691,812
Ensembl chr 2:83,678,521...83,691,400
G
ENPEP
glutamyl aminopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:111,765,839...111,858,349
Ensembl chr 8:111,748,514...111,858,510
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased activity:serum:
CTD RGD
PMID:17072980 PMID:17850827 PMID:20957682
RGD:9685426 RGD:9685427
NCBI chr 4:19,319,815...19,433,492
Ensembl chr 4:19,319,810...19,433,488
G
ENTPD2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
RGD
PMID:15651265
RGD:9685530
G
EPB41L2
erythrocyte membrane protein band 4.1 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:32,418,210...32,630,643
Ensembl chr 1:32,418,217...32,630,638
G
EPCAM
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:93,169,800...93,185,221
Ensembl chr 3:93,168,852...93,185,653
G
ERAP1
endoplasmic reticulum aminopeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:103,378,428...103,415,066
Ensembl chr 2:103,378,429...103,408,759
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
G
EXTL1
exostosin like glycosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:83,461,421...83,476,601
Ensembl chr 6:83,462,323...83,476,596
G
EZR
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:8,403,362...8,452,750
Ensembl chr 1:8,403,453...8,452,742
G
F2R
coagulation factor II thrombin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:85,642,794...85,659,133
Ensembl chr 2:85,641,474...85,656,636
G
F5
coagulation factor V
treatment
ISO
RGD
PMID:17431769
RGD:7394781
NCBI chr 4:81,403,273...81,484,908
Ensembl chr 4:81,403,274...81,485,066
G
FABP2
fatty acid binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:104,464,342...104,468,059
Ensembl chr 8:104,464,342...104,470,480
G
FABP7
fatty acid binding protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 1:39,872,198...39,876,272
Ensembl chr 1:39,871,537...39,876,397
G
FAHD1
fumarylacetoacetate hydrolase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:121,538,308...121,539,037
Ensembl chr 3:40,141,132...40,141,806
G
FAM167B
family with sequence similarity 167 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:88,715,710...88,717,272
Ensembl chr 6:88,715,794...88,717,269
G
FAM43A
family with sequence similarity 43 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:131,662,474...131,665,653
Ensembl chr13:131,663,310...131,665,439
G
FAM89A
family with sequence similarity 89 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:59,367,745...59,388,793
Ensembl chr14:59,367,739...59,388,749
G
FAS
Fas cell surface death receptor
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17105443 PMID:30737368
RGD:2290284
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FAT1
FAT atypical cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:8,466,099...8,580,715
Ensembl chr17:8,457,187...8,580,715
G
FBN1
fibrillin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:123,102,011...123,359,649
Ensembl chr 1:123,102,009...123,359,649
G
FBXO9
F-box protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:46,723,579...46,748,132
Ensembl chr 7:46,723,680...46,748,121
G
FCER1G
Fc epsilon receptor Ig
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:89,242,467...89,246,344
Ensembl chr 4:89,242,472...89,246,450
G
FCGR1A
Fc fragment of IgG, high affinity Ia, receptor (CD64)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:99,233,632...99,242,531
Ensembl chr 4:99,233,611...99,242,586
G
FCGR3A
Fc fragment of IgG receptor IIIa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:88,948,357...88,956,513
G
FCN2
ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:274,106,276...274,111,970
Ensembl chr 1:274,103,877...274,111,970
G
FGF2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16116963
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
G
FGFR1
fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:21543745
RGD:25440477
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
FGG
fibrinogen gamma chain
ISO
mRNA:increased expression
RGD
PMID:17054587
RGD:1599810
NCBI chr 8:74,553,040...74,562,151
Ensembl chr 8:74,553,105...74,563,688
G
FGL2
fibrinogen like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:102,869,044...102,875,564
Ensembl chr 9:102,868,802...102,875,576
G
FGR
FGR proto-oncogene, Src family tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:84,809,534...84,830,401
Ensembl chr 6:84,809,542...84,830,361
G
FHL1
four and a half LIM domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:111,309,989...111,367,900
Ensembl chr X:111,356,011...111,367,903
G
FHL2
four and a half LIM domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:49,389,900...49,448,459
Ensembl chr 3:49,363,555...49,467,527
G
FKBP1A
FKBP prolyl isomerase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:33,910,047...33,935,212
G
FLI1
Fli-1 proto-oncogene, ETS transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:55,612,905...55,749,784
Ensembl chr 9:55,612,901...55,749,778
G
FLNA
filamin A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:124,889,934...124,915,000
Ensembl chr X:124,890,162...124,914,992
G
FMNL1
formin like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:18,198,764...18,225,621
Ensembl chr12:18,198,769...18,225,365
G
FMNL2
formin like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:60,054,300...60,384,666
Ensembl chr15:60,053,877...60,384,655
G
FMO1
flavin containing dimethylaniline monoxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 9:63,860,957...63,895,086
Ensembl chr 9:63,868,064...63,895,076
G
FN1
fibronectin 1
treatment
ISO
mRNA:altered expression:liver (rat) mRNA:increased expression:liver:
RGD
PMID:15980055 PMID:19914391
RGD:1625201 RGD:4140452
NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,043
G
FOLR2
folate receptor 2 (fetal)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:6,785,308...6,790,466
Ensembl chr 9:6,785,303...6,790,465
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
G
FOXA2
forkhead box A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:29,997,397...30,001,704
Ensembl chr17:29,997,401...30,001,707
G
FOXO1
forkhead box O1
ISO
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr11:15,317,222...15,410,059
Ensembl chr11:15,317,124...15,410,473
G
FRY
FRY microtubule binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:8,518,514...8,765,089
Ensembl chr11:8,518,715...8,763,899
G
FSTL1
follistatin like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:139,847,246...139,901,972
Ensembl chr13:139,847,438...139,901,965
G
FTCD
formimidoyltransferase cyclodeaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
FXYD2
FXYD domain containing ion transport regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:45,165,314...45,172,440
G
FXYD5
FXYD domain containing ion transport regulator 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:44,682,245...44,696,088
G
FXYD6
FXYD domain containing ion transport regulator 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:45,182,396...45,218,249
G
FYN
FYN proto-oncogene, Src family tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:77,584,675...77,810,605
Ensembl chr 1:77,585,439...77,810,581
G
FZD8
frizzled class receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:58,093,980...58,096,790
Ensembl chr10:58,094,689...58,096,769
G
G0S2
G0/G1 switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:133,287,065...133,288,066
Ensembl chr 9:133,287,325...133,287,742
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:19,965,885...19,975,783
Ensembl chr12:19,965,330...19,975,857
G
GAB1
GRB2 associated binding protein 1
ISO
protein:increased tyrosine phosphorylation: :
RGD
PMID:25617348
RGD:14995329
NCBI chr 8:84,257,958...84,391,511
Ensembl chr 8:84,257,965...84,391,914
G
GALC
galactosylceramidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:109,894,576...109,961,407
Ensembl chr 7:109,894,578...109,961,413
G
GASK1B
golgi associated kinase 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:47,036,905...47,133,914
Ensembl chr 8:47,036,899...47,098,718
G
GBP2
guanylate binding protein 2, interferon-inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:127,387,222...127,408,729
Ensembl chr 4:127,379,740...127,408,699
G
GC
GC vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
G
GCAT
glycine C-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:10,027,133...10,038,494
Ensembl chr 5:10,027,044...10,038,433
G
GCHFR
GTP cyclohydrolase I feedback regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:130,559,223...130,563,598
Ensembl chr 1:130,554,978...130,559,597
G
GCNT1
glucosaminyl (N-acetyl) transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:229,429,020...229,602,834
Ensembl chr 1:229,429,066...229,468,268
G
GET1
guided entry of tail-anchored proteins factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:202,962,652...202,978,390
Ensembl chr13:202,962,664...202,979,902
G
GFAP
glial fibrillary acidic protein
ISO
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)
RGD
PMID:29323718
RGD:38599216
NCBI chr12:18,456,268...18,466,594
Ensembl chr12:18,456,263...18,466,592
G
GFRA1
GDNF family receptor alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:126,273,558...126,499,957
Ensembl chr14:126,277,875...126,499,465
G
GGH
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:70,996,730...71,020,513
Ensembl chr 4:70,996,755...71,021,838
G
GGTA1
glycoprotein alpha-galactosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:261,511,304...261,587,968
G
GHR
growth hormone receptor
ISO
mRNA, protein:decreased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12679928 PMID:17072980 PMID:25380136
RGD:2307378
NCBI chr16:27,126,300...27,422,618
Ensembl chr16:27,126,734...27,421,449
G
GJA1
gap junction protein alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156
G
GJA4
gap junction protein alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:91,045,430...91,048,161
Ensembl chr 6:91,045,394...91,048,162
G
GK
glycerol kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:26,470,422...26,558,892
G
GLIPR1
GLI pathogenesis related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:38,758,594...38,811,857
Ensembl chr 5:38,766,998...38,815,597
G
GLS
glutaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:95,513,414...95,606,029
Ensembl chr15:95,513,446...95,598,311
G
GLS2
glutaminase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:21,806,405...21,820,001
Ensembl chr 5:21,806,406...21,820,001
G
GLT8D1
glycosyltransferase 8 domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:34,828,601...34,839,854
Ensembl chr13:34,828,604...34,839,794
G
GMFG
glia maturation factor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:47,990,241...47,997,332
Ensembl chr 6:47,990,237...47,997,260
G
GNA14
G protein subunit alpha 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:230,341,947...230,545,123
Ensembl chr 1:230,341,942...230,546,120
G
GNAI2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:32,705,326...32,733,804
Ensembl chr13:32,705,321...32,733,794
G
GNPDA1
glucosamine-6-phosphate deaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:143,604,362...143,616,037
Ensembl chr 2:143,604,362...143,615,990
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr14:110,608,422...110,635,825
Ensembl chr14:110,608,430...110,635,874
G
GPAM
glycerol-3-phosphate acyltransferase, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:122,538,600...122,582,390
Ensembl chr14:122,538,491...122,579,436
G
GPNMB
glycoprotein nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:92,037,428...92,071,501
Ensembl chr 9:92,037,509...92,071,499
G
GPR68
G protein-coupled receptor 68
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:112,885,160...112,904,214
Ensembl chr 7:112,885,163...112,904,246
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:22706148
RGD:8552768
NCBI chr 4:297,747...302,498
Ensembl chr 4:297,748...320,056
G
GPX8
glutathione peroxidase 8 (putative)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:34,336,154...34,341,861
Ensembl chr16:34,336,073...34,342,403
G
GRK2
G protein-coupled receptor kinase 2
ISO
protein:increased expression:aorta
RGD
PMID:17256744
RGD:1625784
NCBI chr 2:5,209,435...5,227,543
Ensembl chr 2:5,209,439...5,227,758
G
GRN
granulin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:18,893,772...18,900,444
Ensembl chr12:18,893,770...18,900,446
G
GSN
gelsolin
ISO
mRNA, protein:increased expression CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14574581 PMID:25380136
RGD:1599866
NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
G
GSTA1
glutathione S-transferase alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:46,538,743...46,550,781
Ensembl chr 7:46,538,032...46,548,670
G
GSTA4
glutathione S-transferase alpha 4
treatment
ISO
RGD
PMID:23075396
RGD:9685568
NCBI chr 7:46,635,903...46,656,491
Ensembl chr 7:46,635,902...46,656,450
G
GULP1
GULP PTB domain containing engulfment adaptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:92,988,094...93,252,188
Ensembl chr15:92,911,054...93,252,180
G
GZMA
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:34,282,160...34,290,422
Ensembl chr16:34,282,120...34,290,477
G
HAGH
hydroxyacylglutathione hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:40,139,099...40,162,921
G
HAL
histidine ammonia-lyase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:87,522,483...87,547,489
Ensembl chr 5:87,522,542...87,547,455
G
HAO1
hydroxyacid oxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:16,746,153...16,802,460
Ensembl chr17:16,744,442...16,802,442
G
HAO2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 4:101,588,510...101,787,818
Ensembl chr 4:101,588,861...101,732,304
G
HCK
HCK proto-oncogene, Src family tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:35,708,549...35,751,590
Ensembl chr17:35,709,349...35,751,582
G
HELLS
helicase, lymphoid specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:105,923,727...105,967,003
Ensembl chr14:105,924,536...105,955,430
G
HEXIM1
HEXIM P-TEFb complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:18,267,023...18,270,089
Ensembl chr12:18,267,027...18,269,165
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10677585 PMID:12918455 PMID:15793283 PMID:16465399 PMID:16627068 PMID:17714472 PMID:18637143 More...
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HIP1
huntingtin interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:10,416,418...10,578,374
Ensembl chr 3:10,416,475...10,578,366
G
HJV
hemojuvelin BMP co-receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:99,327,989...99,332,647
Ensembl chr 4:99,328,053...99,332,645
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
G
HMOX1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:16025519 PMID:16610050 PMID:19554654 PMID:21163135 PMID:25380136
RGD:4145305
G
HOPX
HOP homeobox
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:55,862,191...55,901,628
G
HOXA3
homeobox A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:45,421,542...45,467,803
Ensembl chr18:45,454,213...45,466,537
G
HP
haptoglobin
ISO
protein:decreased expression:serum protein:increased expression:serum
RGD
PMID:16968543 PMID:21806828
RGD:1626367 RGD:9491781
NCBI chr 6:14,980,382...14,985,245
G
HPCAL1
hippocalcin like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:126,107,407...126,220,381
Ensembl chr 3:126,107,412...126,220,309
G
HPGDS
hematopoietic prostaglandin D synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:125,375,906...125,406,066
Ensembl chr 8:125,375,867...125,405,955
G
HPSE
heparanase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15095483 PMID:18458672
NCBI chr 8:135,082,199...135,120,887
Ensembl chr 8:135,097,725...135,120,887
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 6:6,296,429...6,360,434
Ensembl chr 6:6,292,707...6,360,633
G
HSD17B6
hydroxysteroid 17-beta dehydrogenase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 5:22,089,496...22,114,319
Ensembl chr 5:22,092,578...22,273,382
G
HTR2B
5-hydroxytryptamine receptor 2B
ISO
protein:increased expression:liver (rat)
RGD
PMID:16936262
RGD:9743846
NCBI chr15:131,844,578...131,860,417
Ensembl chr15:131,844,992...131,859,277
G
HYKK
hydroxylysine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:47,451,822...47,474,778
Ensembl chr 7:47,449,036...47,474,648
G
ICAM2
intercellular adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:14,986,636...14,991,639
Ensembl chr12:14,972,852...14,997,428
G
ID2
inhibitor of DNA binding 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17127702
NCBI chr 3:127,500,759...127,503,207
Ensembl chr 3:127,500,763...127,503,257
G
ID4
inhibitor of DNA binding 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:15,281,535...15,284,895
Ensembl chr 7:15,281,757...15,282,839
G
IDO1
indoleamine 2,3-dioxygenase 1
severity
ISO
protein:increased expression:serum (mouse)
RGD
PMID:28465467
RGD:39939037
NCBI chr17:9,245,283...9,260,140
Ensembl chr17:9,245,196...9,260,473
G
IDUA
alpha-L-iduronidase
ISO
protein:increased expression:liver
RGD
PMID:6875476
RGD:12910840
NCBI chr 8:334,604...351,970
Ensembl chr 8:334,617...351,969
G
IFI35
interferon induced protein 35
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:19,879,386...19,890,330
Ensembl chr12:19,879,387...19,890,314
G
IFNA1
interferon, alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12898905 PMID:14512876 PMID:16027843
NCBI chr 1:201,515,835...201,516,477
Ensembl chr 1:201,515,809...201,516,488
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: therapeutic protein:increased expression:serum (mouse)
CTD RGD
PMID:12389079 PMID:15996030 PMID:16953842 PMID:17347453 PMID:28465467
RGD:39939037
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IFNGR1
interferon gamma receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:27,037,151...27,061,095
Ensembl chr 1:27,037,165...27,061,093
G
IFRD1
interferon related developmental regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:33,198,002...33,248,912
Ensembl chr18:33,193,426...33,248,297
G
IGF1
insulin like growth factor 1
treatment
ISO
protein:increased expression:liver: CTD Direct Evidence: therapeutic
RGD CTD
PMID:12800242 PMID:15591519 PMID:15745444 PMID:16434425 PMID:20198635
RGD:10045984 RGD:12904923 RGD:2317647
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:increased expression:liver:
RGD
PMID:12800242
RGD:10045984
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058
G
IGF2BP3
insulin like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:92,104,786...92,272,264
Ensembl chr 9:92,104,848...92,272,211
G
IGF2R
insulin like growth factor 2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:7,369,485...7,472,480
Ensembl chr 1:7,368,103...7,472,548
G
IGFALS
insulin like growth factor binding protein acid labile subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:40,173,595...40,177,789
Ensembl chr 3:40,174,764...40,177,784
G
IGFBP1
insulin like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr18:50,018,487...50,022,799
Ensembl chr18:50,018,487...50,022,799
G
IGFBP2
insulin like growth factor binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr15:118,822,092...118,850,985
Ensembl chr15:118,822,047...118,850,976
G
IGFBP3
insulin like growth factor binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:50,002,921...50,009,425
Ensembl chr18:50,003,022...50,010,690
G
IGFBP7
insulin like growth factor binding protein 7
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25380136 PMID:25691930
RGD:401976485
NCBI chr 8:56,283,089...56,357,822
Ensembl chr 8:56,279,895...56,357,822
G
IGSF6
immunoglobulin superfamily member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:23,673,162...23,683,256
Ensembl chr 3:23,673,148...23,683,864
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:125,035,575...125,056,445
Ensembl chr X:125,036,508...125,056,453
G
IL10
interleukin 10
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12632514 PMID:15362042 PMID:16097045 PMID:16126171 PMID:16539848 PMID:16552806 PMID:16609999 PMID:16688825 PMID:18251166 PMID:23980370 PMID:24993843 More...
RGD:11049490 RGD:7364982
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL17A
interleukin 17A
treatment
ISO
protein:increased expression:liver, serum (mouse)
RGD
PMID:28465467 PMID:30346985
RGD:151665755 RGD:39939037
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL17RA
interleukin 17 receptor A
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr 5:69,461,280...69,480,343
Ensembl chr 5:69,461,290...69,480,112
G
IL17RC
interleukin 17 receptor C
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr13:66,179,298...66,194,750
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL18BP
interleukin 18 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:6,586,602...6,596,423
Ensembl chr 9:6,488,808...6,591,333
G
IL2
interleukin 2
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL2RB
interleukin 2 receptor subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:10,610,094...10,650,315
Ensembl chr 5:10,628,962...10,650,314
G
IL2RG
interleukin 2 receptor subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:57,143,568...57,151,242
Ensembl chr X:57,143,570...57,147,256
G
IL33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
IL4
interleukin 4
ISO
protein:decreased expression:serum (mouse)
RGD
PMID:28465467
RGD:39939037
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL6
interleukin 6
treatment
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:24383550 PMID:28465467 PMID:30346985
RGD:10450610 RGD:151665755 RGD:39939037
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
IL7R
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:21,300,141...21,330,156
Ensembl chr16:21,300,111...21,329,585
G
ILK
integrin linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16941698
NCBI chr 9:3,145,647...3,152,097
Ensembl chr 9:3,145,608...3,159,858
G
INHBC
inhibin subunit beta C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:22,718,416...22,728,766
Ensembl chr 5:22,718,491...22,730,087
G
INHBE
inhibin subunit beta E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 5:22,732,774...22,734,716
Ensembl chr 5:22,732,516...22,734,083
G
INMT
indolethylamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:42,213,335...42,218,175
Ensembl chr18:42,209,352...42,218,174
G
INPP5D
inositol polyphosphate-5-phosphatase D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:133,501,067...133,626,647
Ensembl chr15:133,501,092...133,626,644
G
INPPL1
inositol polyphosphate phosphatase like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:6,793,971...6,807,286
Ensembl chr 9:6,793,069...6,808,028
G
INS
insulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26806094
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
G
INSIG2
insulin induced gene 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:23,676,684...23,699,591
Ensembl chr15:23,676,683...23,699,582
G
IRF8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:3,041,617...3,060,685
Ensembl chr 6:3,041,645...3,097,406
G
ISG20
interferon stimulated exonuclease gene 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:191,155,853...191,195,601
Ensembl chr 1:191,183,599...191,195,475
G
ISYNA1
inositol-3-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:59,363,672...59,367,003
Ensembl chr 2:59,363,716...59,367,002
G
ITGA2B
integrin subunit alpha 2b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:18,860,739...18,877,381
Ensembl chr12:18,860,739...18,877,381
G
ITGAL
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:17,817,785...17,858,057
Ensembl chr 3:17,817,011...17,858,012
G
ITGB1
integrin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326
G
ITGB2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:207,514,281...207,544,108
Ensembl chr13:207,512,950...207,544,107
G
ITGB3
integrin subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
G
ITGB6
integrin subunit beta 6
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18221819 PMID:18538673
RGD:2302244
NCBI chr15:67,041,516...67,175,409
Ensembl chr15:67,041,522...67,175,234
G
IVD
isovaleryl-CoA dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:130,896,488...130,910,582
Ensembl chr 1:130,893,984...130,910,586
G
IYD
iodotyrosine deiodinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:15,756,536...15,779,380
Ensembl chr 1:15,756,550...15,779,164
G
JAK2
Janus kinase 2
ISO
protein:increased expression, increased tyrosine phosphorylation:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:24619965 PMID:25380136
RGD:10403061
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
JDP2
Jun dimerization protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:98,574,386...98,616,480
Ensembl chr 7:98,575,667...98,616,474
G
KANK1
KN motif and ankyrin repeat domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:221,015,042...221,218,875
Ensembl chr 1:221,015,046...221,078,245
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:51,695,927...51,704,402
Ensembl chr 5:51,696,188...51,703,813
G
KCNN4
potassium calcium-activated channel subfamily N member 4
exacerbates
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:27354175
RGD:329955558
NCBI chr 6:50,580,016...50,593,518
Ensembl chr 6:50,580,022...50,593,544
G
KLF6
KLF transcription factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:66,488,445...66,497,830
Ensembl chr10:66,488,391...66,497,844
G
KMO
kynurenine 3-monooxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:12,442,877...12,489,417
Ensembl chr10:12,442,645...12,490,409
G
KNG1
kininogen 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18054572
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
G
KRT18
keratin 18
ISO
protein:increased expression:liver, plasma membrane (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15999547 PMID:17072980 PMID:18395095 PMID:21138630 PMID:25380136
RGD:27226809
NCBI chr 5:18,217,686...18,221,432
Ensembl chr 5:18,217,691...18,221,429
G
KRT19
keratin 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:21,115,453...21,119,115
Ensembl chr12:21,115,448...21,119,107
G
KRT8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 5:18,172,423...18,180,277
Ensembl chr 5:18,167,553...18,180,404
G
KTN1
kinectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:184,881,555...184,990,936
Ensembl chr 1:184,881,550...185,152,975
G
KYNU
kynureninase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:8,847,335...8,982,951
Ensembl chr15:8,850,544...8,982,891
G
L3HYPDH
trans-L-3-hydroxyproline dehydratase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:188,584,363...188,616,688
Ensembl chr 1:188,584,377...188,610,002
G
LAPTM5
lysosomal protein transmembrane 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:87,363,911...87,390,371
Ensembl chr 6:87,363,911...87,390,347
G
LBH
LBH regulator of WNT signaling pathway
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:109,078,285...109,113,536
Ensembl chr 3:109,078,286...109,105,529
G
LBP
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr17:41,398,935...41,429,467
Ensembl chr17:41,398,791...41,429,551
G
LCN2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644
G
LCP1
lymphocyte cytosolic protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:21,126,504...21,223,543
Ensembl chr11:21,126,539...21,223,550
G
LCP2
lymphocyte cytosolic protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:53,696,974...53,741,736
Ensembl chr16:53,697,026...53,741,725
G
LDHB
lactate dehydrogenase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:51,810,932...51,831,218
G
LEFTY2
left-right determination factor 2
ameliorates
ISO
RGD
PMID:34887753
RGD:401794438
NCBI chr10:13,849,052...13,853,438
Ensembl chr10:13,848,174...13,853,438
G
LEP
leptin
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586293 PMID:16097051 PMID:19065677 PMID:20509998 PMID:29248466
RGD:5128589 RGD:5128713
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LEPR
leptin receptor
ISO
protein:increased expression:serum
RGD
PMID:23886859
RGD:10412036
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
G
LGALS1
galectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:10,149,069...10,152,514
Ensembl chr 5:10,149,068...10,156,023
G
LGALS2
galectin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:10,237,772...10,244,555
Ensembl chr 5:10,237,745...10,250,162
G
LGALS3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12646584 PMID:16549783 PMID:25380136
RGD:9685223 RGD:9685224
NCBI chr 1:184,478,639...184,496,155
Ensembl chr 1:184,478,710...184,497,951
G
LGALSL
galectin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:77,472,153...77,479,415
Ensembl chr 3:77,472,166...77,479,361
G
LGMN
legumain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:114,176,217...114,210,096
Ensembl chr 7:114,173,693...114,217,102
G
LHFPL6
LHFPL tetraspan subfamily member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:14,319,420...14,576,130
Ensembl chr11:14,319,428...14,560,181
G
LIMK2
LIM domain kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:47,983,984...48,039,631
Ensembl chr14:47,983,975...48,040,821
G
LIN7A
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:100,533,630...100,686,709
Ensembl chr 5:100,538,065...100,674,551
G
LMO2
LIM domain only 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:27,033,924...27,055,457
Ensembl chr 2:27,044,763...27,055,453
G
LOC100157117
kallistatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:115,781,772...115,792,469
Ensembl chr 7:115,783,931...115,792,466
G
LOC100512795
alcohol dehydrogenase class 4 mu/sigma chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:121,020,683...121,041,735
Ensembl chr 8:121,020,969...121,041,506
G
LOC100519934
uncharacterized LOC100519934
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:73,119,758...73,124,368
G
LOC100522887
caspase-13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:35,167,567...35,185,791
G
LOC100623616
arylacetamide deacetylase-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:92,017,495...92,042,944
Ensembl chr13:92,017,548...92,042,938
G
LOC100623720
collagen alpha-1(VI) chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:208,295,245...208,321,789
Ensembl chr13:208,295,451...208,313,127
G
LOC100625684
olfactory receptor 51E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:5,431,098...5,434,483
Ensembl chr 9:5,432,611...5,433,573
G
LOC102161418
interferon-induced transmembrane protein 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:156,364...157,650
G
LOC110255211
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:25,334,619...25,340,775
G
LOC110256626
proline dehydrogenase 1, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:51,624,919...51,644,467
G
LOC110258578
interleukin-1 beta-like
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16085334 PMID:24383550
RGD:10450610
G
LOC110258709
C-type lectin domain family 4 member A-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
LOX
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:125,595,115...125,607,026
Ensembl chr 2:125,591,789...125,607,594
G
LOXL2
lysyl oxidase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:7,435,861...7,540,699
Ensembl chr14:7,435,867...7,540,704
G
LPL
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:4,104,761...4,134,964
Ensembl chr14:4,104,772...4,135,814
G
LPXN
leupaxin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:12,534,780...12,582,756
Ensembl chr 2:12,540,098...12,582,752
G
LRAT
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:74,412,226...74,428,713
Ensembl chr 8:74,409,461...74,419,681
G
LRP6
LDL receptor related protein 6
ISO
RGD
PMID:18006602
RGD:4110127
NCBI chr 5:60,149,041...60,318,719
Ensembl chr 5:60,149,028...60,314,662
G
LRRC28
leucine rich repeat containing 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:137,998,540...138,194,848
Ensembl chr 1:137,998,554...138,203,466
G
LRRFIP1
LRR binding FLII interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:137,283,262...137,439,383
Ensembl chr15:137,283,276...137,439,385
G
LTA4H
leukotriene A4 hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:87,486,552...87,518,520
Ensembl chr 5:87,486,512...87,518,515
G
LTB
lymphotoxin beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:23,704,842...23,707,036
Ensembl chr 7:23,704,841...23,706,745
G
LTBP1
latent transforming growth factor beta binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:106,300,748...106,724,538
Ensembl chr 3:106,300,750...106,724,737
G
LUM
lumican
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:91,748,871...91,756,381
Ensembl chr 5:91,748,885...91,757,598
G
LURAP1L
leucine rich adaptor protein 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:209,621,712...209,668,924
Ensembl chr 1:209,620,907...209,668,913
G
LY86
lymphocyte antigen 86
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:4,108,124...4,156,629
Ensembl chr 7:4,108,118...4,156,625
G
LY96
lymphocyte antigen 96
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:61,919,806...61,950,712
Ensembl chr 4:61,926,064...61,950,697
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:37,957,830...37,959,505
Ensembl chr17:37,957,507...37,959,505
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:27396351
RGD:13800880
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:27396351
RGD:13800880
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19793108
RGD:2316776
NCBI chr 1:7,527,566...7,542,110
Ensembl chr 1:7,527,861...7,528,838
G
MDH1
malate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:78,247,229...78,263,085
Ensembl chr 3:78,244,999...78,268,600
G
MEOX2
mesenchyme homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:84,945,178...85,009,939
Ensembl chr 9:84,943,199...85,010,157
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
protein:decreased expression:liver (rat)
RGD
PMID:16958060
RGD:2317516
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
METRNL
meteorin like, glial cell differentiation regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:228,228...241,491
Ensembl chr12:228,503...241,496
G
MFAP4
microfibril associated protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:60,141,488...60,144,214
Ensembl chr12:60,137,566...60,144,207
G
MFN2
mitofusin 2
treatment
ISO
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:25369251 PMID:26882442
RGD:12910839 RGD:13204798
NCBI chr 6:72,026,512...72,056,439
Ensembl chr 6:72,028,499...72,056,438
G
MGAT5
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23798564
NCBI chr15:17,544,806...17,919,273
Ensembl chr15:17,544,806...17,918,555
G
MGMT
O-6-methylguanine-DNA methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:138,502,005...138,771,543
Ensembl chr14:138,499,309...138,771,540
G
MGP
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:57,665,272...57,669,360
Ensembl chr 5:57,665,248...57,669,764
G
MID1IP1
MID1 interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:34,763,360...34,766,160
Ensembl chr X:34,763,355...34,766,076
G
MIF
macrophage migration inhibitory factor
ISO
protein:increased expression:hepatocyte
RGD
PMID:14706927
RGD:1642000
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MINDY3
MINDY lysine 48 deubiquitinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:45,980,088...46,062,700
Ensembl chr10:45,980,111...46,062,700
G
MIR122
microRNA mir-122
treatment
ISO
RGD
PMID:28987423
RGD:14401600
NCBI chr 1:162,329,776...162,329,860
Ensembl chr 1:162,329,767...162,329,860
G
MIR152
microRNA mir-152
treatment
ISO
miRNA:decreased expression:liver
RGD
PMID:26257392 PMID:31258681
RGD:19165150 RGD:19165153
NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336
G
MIR17
microRNA mir-17
treatment
ISO
RGD
PMID:28177765
RGD:329403059
NCBI chr11:60,734,656...60,734,732
Ensembl chr11:60,734,656...60,734,732
G
MIR30A
microRNA mir-30a
treatment
ISO
RGD
PMID:29587268
RGD:35673290
NCBI chr 1:51,412,827...51,412,933
Ensembl chr 1:51,412,827...51,412,933
G
MIS12
MIS12 kinetochore complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:51,505,376...51,508,337
Ensembl chr12:51,505,381...51,507,943
G
MKI67
marker of proliferation Ki-67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:137,266,622...137,296,312
G
MME
membrane metalloendopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16085334
NCBI chr13:95,018,395...95,122,977
Ensembl chr13:95,019,081...95,126,045
G
MMP1
matrix metallopeptidase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12557150
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
MMP13
matrix metallopeptidase 13
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:10623612 PMID:17404313
RGD:10043161
NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162
G
MMP15
matrix metallopeptidase 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:19,890,867...19,912,941
Ensembl chr 6:19,891,107...19,912,913
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15095483 PMID:25380136
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP8
matrix metallopeptidase 8
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15057751
NCBI chr 9:33,384,034...33,397,637
Ensembl chr 9:33,384,033...33,396,947
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15095483
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MOB3A
MOB kinase activator 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:76,475,397...76,495,015
Ensembl chr 2:76,475,530...76,496,060
G
MRO
maestro
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:100,342,040...100,368,355
Ensembl chr 1:100,343,462...100,368,354
G
MSN
moesin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:51,844,197...51,967,674
Ensembl chr X:51,844,156...51,970,107
G
MT-2B
metallothionein-2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:18,645,125...18,646,034
Ensembl chr 6:18,645,153...18,646,033
G
MT-CYB
mitochondrially encoded cytochrome b
ISO
protein:increased expression:mitochondrion, liver
RGD
PMID:2836123
RGD:2298972
NCBI chr MT:15,342...16,481
Ensembl chr MT:15,342...16,481
G
MT1A
metallothionein 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 6:18,672,016...18,673,673
Ensembl chr 6:18,672,001...18,673,672
G
MTMR7
myotubularin related protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:5,007,560...5,122,367
Ensembl chr17:5,006,623...5,122,201
G
MTOR
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:25454463
RGD:10040998
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MVP
major vault protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:18,056,548...18,081,169
Ensembl chr 3:18,057,177...18,081,155
G
MYADM
myeloid associated differentiation marker
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:56,236,306...56,278,577
Ensembl chr 6:56,236,311...56,244,185
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
MYL9
myosin light chain 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:39,788,165...39,795,240
Ensembl chr17:39,788,199...39,795,293
G
MYO1C
myosin IC
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:47,691,252...47,715,670
Ensembl chr12:47,691,256...47,718,337
G
MYO1F
myosin IF
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:70,753,143...70,792,938
Ensembl chr 2:70,753,138...70,792,936
G
MYO5A
myosin VA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:119,165,751...119,398,591
Ensembl chr 1:119,165,942...119,394,725
G
MYOC
myocilin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:114,087,370...114,098,765
Ensembl chr 9:114,087,378...114,098,745
G
NAGK
N-acetylglucosamine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:71,496,191...71,513,020
Ensembl chr 3:71,500,337...71,512,955
G
NAP1L5
nucleosome assembly protein 1 like 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:130,364,566...130,365,464
Ensembl chr 8:130,364,566...130,365,464
G
NAT8
N-acetyltransferase 8 (putative)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:69,250,326...69,254,079
G
NBEA
neurobeachin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:11,085,081...11,722,859
Ensembl chr11:11,084,992...11,722,847
G
NCKAP1L
NCK associated protein 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:19,677,613...19,720,550
Ensembl chr 5:19,677,875...19,723,132
G
NCOR2
nuclear receptor corepressor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:28,642,774...28,819,404
Ensembl chr14:28,624,702...28,819,404
G
NDRG1
N-myc downstream regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:8,014,445...8,069,335
Ensembl chr 4:8,014,446...8,069,335
G
NDRG2
NDRG family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:78,111,736...78,121,216
Ensembl chr 7:78,112,536...78,121,215
G
NECTIN2
nectin cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:51,317,386...51,358,665
G
NEK6
NIMA related kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:265,078,407...265,170,960
Ensembl chr 1:265,078,435...265,176,903
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23341968
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NFKBIA
NFKB inhibitor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26806094
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
G
NFKBIE
NFKB inhibitor epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:39,255,078...39,266,085
Ensembl chr 7:39,255,075...39,263,339
G
NFKBIZ
NFKB inhibitor zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:157,261,419...157,273,119
Ensembl chr13:157,261,419...157,272,688
G
NHSL3
NHS like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:89,058,857...89,087,840
Ensembl chr 6:89,058,808...89,087,839
G
NID1
nidogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:55,239,327...55,346,948
Ensembl chr14:55,239,577...55,390,782
G
NID2
nidogen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:181,699,098...181,773,084
Ensembl chr 1:181,699,106...181,815,167
G
NIPAL2
NIPA like domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:38,491,029...38,576,606
Ensembl chr 4:38,491,285...38,574,255
G
NLRC5
NLR family CARD domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26806094
NCBI chr 6:18,933,179...19,036,288
Ensembl chr 6:18,937,677...19,036,820
G
NMI
N-myc and STAT interactor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:941,379...966,519
Ensembl chr15:941,475...967,321
G
NOCT
nocturnin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:87,885,411...87,909,231
Ensembl chr 8:87,885,420...87,909,241
G
NOS2
nitric oxide synthase 2
ISO
mRNA:increased expression:aorta CTD Direct Evidence: therapeutic mRNA:increased expression:heart
RGD CTD
PMID:10353629 PMID:10784593 PMID:18380797
RGD:2325265 RGD:2325278
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NOS3
nitric oxide synthase 3
ISO
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism protein:decreased expression:spleen
RGD CTD
PMID:17481668 PMID:17918268 PMID:18555214
RGD:2292126 RGD:2292140
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
NOX4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:22,622,105...22,776,691
Ensembl chr 9:22,624,212...22,776,534
G
NPAS2
neuronal PAS domain protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:53,298,805...53,490,375
Ensembl chr 3:53,298,811...53,490,574
G
NPDC1
neural proliferation, differentiation and control 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
NQO2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:1,792,745...1,805,916
Ensembl chr 7:1,792,876...1,806,301
G
NR0B2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 6:84,225,670...84,228,156
Ensembl chr 6:84,225,694...84,228,481
G
NR1H4
nuclear receptor subfamily 1 group H member 4
treatment
ISO
associated with portal hypertension;mRNA;decreased expression;liver (rat) mRNA:altered expression:liver (rat)
RGD
PMID:15980055 PMID:24259407 PMID:27993716
RGD:14701034 RGD:15045598 RGD:1625201
NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
G
NREP
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:117,505,851...117,867,805
Ensembl chr 2:117,838,660...117,867,801
G
NRG1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:52,625,550...53,688,003
Ensembl chr15:52,630,679...52,839,505
G
NRROS
negative regulator of reactive oxygen species
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:133,470,641...133,496,218
Ensembl chr13:133,470,645...133,496,223
G
NSMF
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
NT5E
5'-nucleotidase ecto
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18263696
NCBI chr 1:54,400,786...54,450,743
Ensembl chr 1:54,400,810...54,448,742
G
NUDT16
nudix hydrolase 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:1,125,180...1,128,036
Ensembl chr13:1,125,183...1,128,041
G
NUPR1
nuclear protein 1, transcriptional regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:18,402,781...18,404,411
Ensembl chr 3:18,402,935...18,511,087
G
OAT
ornithine aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:133,808,193...133,830,517
Ensembl chr14:133,808,193...133,830,761
G
OGG1
8-oxoguanine DNA glycosylase
treatment
ISO
RGD
PMID:23053977
RGD:8657403
NCBI chr13:66,038,669...66,045,478
G
OLFML2B
olfactomedin like 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:88,522,171...88,560,305
Ensembl chr 4:88,522,240...88,560,306
G
OLFML3
olfactomedin like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:106,566,978...106,571,086
Ensembl chr 4:106,563,450...106,569,771
G
OSGIN1
oxidative stress induced growth inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:4,642,762...4,656,113
Ensembl chr 6:4,642,764...4,653,487
G
OSM
oncostatin M
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17640959
NCBI chr14:47,242,767...47,246,836
Ensembl chr14:47,242,774...47,246,838
G
OTC
ornithine transcarbamylase
ISO
CTD Direct Evidence: marker/mechanism protein:decreased activity:liver (rat)
CTD RGD
PMID:7865721 PMID:25380136
RGD:4144080
NCBI chr X:34,322,398...34,391,711
Ensembl chr X:34,322,298...34,391,821
G
OTUB2
OTU deubiquitinase, ubiquitin aldehyde binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:115,304,809...115,326,055
Ensembl chr 7:115,304,871...115,327,054
G
OTULINL
OTU deubiquitinase with linear linkage specificity like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:3,964,300...4,000,673
Ensembl chr16:3,969,932...3,999,778
G
PALMD
palmdelphin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:118,377,246...118,427,800
Ensembl chr 4:118,377,248...118,428,086
G
PAMR1
peptidase domain containing associated with muscle regeneration 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:25,422,390...25,591,615
Ensembl chr 2:25,514,193...25,591,617
G
PAQR9
progestin and adipoQ receptor family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:83,660,387...83,669,522
Ensembl chr13:83,667,736...83,668,869
G
PC
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 2:5,566,608...5,587,797
Ensembl chr 2:5,518,517...5,587,797
G
PCK1
phosphoenolpyruvate carboxykinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr17:57,930,507...57,936,523
Ensembl chr17:57,930,432...57,936,522
G
PCK2
phosphoenolpyruvate carboxykinase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:75,187,195...75,197,613
Ensembl chr 7:75,187,197...75,197,733
G
PDGFA
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:296,399...322,967
Ensembl chr 3:301,584...321,712
G
PDGFRA
platelet derived growth factor receptor alpha
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17382907 PMID:25380136
RGD:11080969
NCBI chr 8:40,966,568...41,021,440
Ensembl chr 8:40,967,493...41,021,441
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15077122 PMID:15623374 PMID:18466260
RGD:10449503 RGD:2292206
NCBI chr 2:151,155,753...151,192,818
Ensembl chr 2:151,155,756...151,192,647
G
PDZRN3
PDZ domain containing ring finger 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:54,659,657...54,904,742
Ensembl chr13:54,659,589...54,904,809
G
PEA15
proliferation and apoptosis adaptor protein 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:90,263,600...90,276,142
Ensembl chr 4:90,263,604...90,276,147
G
PFKP
phosphofructokinase, platelet
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:67,022,652...67,082,336
Ensembl chr10:67,022,655...67,082,449
G
PFN1
profilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:51,962,642...51,965,570
Ensembl chr12:51,961,952...51,965,464
G
PGF
placental growth factor
disease_progression
ISO
RGD
PMID:17935226 PMID:21520176
RGD:1643338 RGD:6483607
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
G
PKD2
polycystin 2, transient receptor potential cation channel
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:131,002,973...131,058,932
Ensembl chr 8:131,005,407...131,058,932
G
PKLR
pyruvate kinase L/R
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:94,536,978...94,546,561
Ensembl chr 4:94,537,019...94,546,555
G
PLA2G12A
phospholipase A2 group XIIA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:112,483,322...112,512,520
Ensembl chr 8:112,483,392...112,512,419
G
PLA2G4A
phospholipase A2 group IVA
ISO
protein:increased activity:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17459512 PMID:25380136
RGD:1642445
NCBI chr 9:127,853,581...128,164,825
Ensembl chr 9:127,859,051...128,162,638
G
PLAC8
placenta associated 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:135,250,761...135,279,091
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20035854 PMID:25380136
RGD:6484134
NCBI chr17:11,195,599...11,223,821
Ensembl chr17:11,195,602...11,224,032
G
PLAU
plasminogen activator, urokinase
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16958060 PMID:20035854 PMID:23018346 PMID:25380136
RGD:2317516 RGD:6484134 RGD:7241553
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
G
PLD4
phospholipase D family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
PLEK
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:73,877,741...73,910,163
Ensembl chr 3:73,877,743...73,906,667
G
PLEKHB1
pleckstrin homology domain containing B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:8,103,497...8,117,819
Ensembl chr 9:8,102,056...8,117,815
G
PLG
plasminogen
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14716496
NCBI chr 1:7,062,399...7,109,521
Ensembl chr 1:7,061,192...7,110,555
G
PLIN2
perilipin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:203,683,867...203,709,277
Ensembl chr 1:203,683,862...203,709,273
G
PLIN3
perilipin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:73,970,149...73,995,314
Ensembl chr 2:73,969,862...73,995,529
G
PLOD2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:86,402,673...86,513,167
Ensembl chr13:86,401,244...86,513,105
G
PLPP2
phospholipid phosphatase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:77,945,760...77,957,318
Ensembl chr 2:77,945,841...77,957,313
G
PLSCR1
phospholipid scramblase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:86,836,288...86,869,569
Ensembl chr13:86,834,587...86,869,297
G
PLTP
phospholipid transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:48,089,789...48,101,604
Ensembl chr17:48,089,786...48,101,515
G
PMEPA1
prostate transmembrane protein, androgen induced 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:57,999,287...58,054,329
Ensembl chr17:57,999,287...58,054,118
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16508911 PMID:16511523
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:18594976 PMID:22529699
RGD:2301874 RGD:8553190
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
PPP1R16A
protein phosphatase 1 regulatory subunit 16A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 4:302,621...320,048
Ensembl chr 4:297,748...320,056
G
PPP1R18
protein phosphatase 1 regulatory subunit 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:23,211,806...23,222,295
Ensembl chr 7:23,211,805...23,222,186
G
PPP1R3B
protein phosphatase 1 regulatory subunit 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:56,002,383...56,013,477
Ensembl chr15:56,002,378...56,013,478
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:103,273,401...103,278,757
Ensembl chr14:103,273,405...103,278,762
G
PRAF2
PRA1 domain family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:43,147,473...43,150,350
G
PRKCB
protein kinase C beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:21,995,227...22,383,628
Ensembl chr 3:21,995,231...22,383,264
G
PRKCD
protein kinase C delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:35,290,835...35,323,245
Ensembl chr13:35,290,610...35,323,356
G
PRKN
parkin RBR E3 ubiquitin protein ligase
treatment
ISO
RGD
PMID:26882442
RGD:12910839
NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872
G
PRLR
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:20,637,568...20,655,881
Ensembl chr16:20,618,875...20,810,140
G
PRNP
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:13,694,195...13,705,126
Ensembl chr17:13,694,190...13,705,124
G
PROCR
protein C receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:38,532,530...38,537,397
Ensembl chr17:38,532,763...38,537,394
G
PRODH2
proline dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:45,213,712...45,240,437
G
PROS1
protein S
ISO
mRNA, protein:decreased expression:liver, plasma
RGD
PMID:16995903
RGD:2300011
NCBI chr13:165,915,298...165,999,118
Ensembl chr13:165,911,366...165,999,811
G
PRR13
proline rich 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:18,660,814...18,665,926
Ensembl chr 5:18,660,814...18,665,925
G
PRTFDC1
phosphoribosyl transferase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:50,365,654...50,458,487
Ensembl chr10:50,365,587...50,461,324
G
PRTG
protogenin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:116,132,269...116,275,678
Ensembl chr 1:116,132,165...116,268,631
G
PRUNE2
prune homolog 2 with BCH domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:229,578,444...229,849,222
G
PSMB10
proteasome 20S subunit beta 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:28,544,910...28,547,609
Ensembl chr 6:28,543,972...28,548,152
G
PSMB8
proteasome 20S subunit beta 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:25,058,456...25,061,666
Ensembl chr 7:25,058,461...25,062,245
G
PSMB9
proteasome 20S subunit beta 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:25,072,133...25,077,508
Ensembl chr 7:25,072,323...25,078,322
G
PSME2
proteasome activator subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:75,154,570...75,157,871
Ensembl chr 7:75,153,965...75,157,870
G
PSTPIP1
proline-serine-threonine phosphatase interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:57,100,212...57,145,278
Ensembl chr 7:57,102,757...57,146,751
G
PTAFR
platelet activating factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:85,235,390...85,272,360
Ensembl chr 6:85,235,394...85,261,760
G
PTER
phosphotriesterase related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:45,368,515...45,440,294
Ensembl chr10:45,362,928...45,440,215
G
PTGER2
prostaglandin E receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:181,993,961...182,009,959
Ensembl chr 1:181,994,560...182,009,953
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17565644 PMID:18555214
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTK2
protein tyrosine kinase 2
ISO
mRNA, protein:increased expression:liver
RGD
PMID:15378782
RGD:2292604
NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054
G
PTN
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:12,219,708...12,309,045
Ensembl chr18:12,219,787...12,309,044
G
PTPN1
protein tyrosine phosphatase non-receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26739621
NCBI chr17:52,017,100...52,086,747
Ensembl chr17:52,017,130...52,086,736
G
PTPN18
protein tyrosine phosphatase non-receptor type 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:31,945,901...31,966,571
Ensembl chr15:31,945,897...31,965,753
G
PTPRC
protein tyrosine phosphatase receptor type C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:21,482,984...21,601,627
Ensembl chr10:21,560,073...21,601,308
G
PTPRD
protein tyrosine phosphatase receptor type D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:211,832,409...214,013,013
Ensembl chr 1:213,483,348...214,009,893
G
PTPRO
protein tyrosine phosphatase receptor type O
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:57,021,819...57,263,395
Ensembl chr 5:57,019,745...57,263,346
G
PTRH1
peptidyl-tRNA hydrolase 1 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:268,213,685...268,215,498
Ensembl chr 1:268,213,687...268,215,523
G
PTRHD1
peptidyl-tRNA hydrolase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:113,979,174...113,982,943
G
PXDN
peroxidasin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:132,306,288...132,362,853
Ensembl chr 3:132,306,447...132,362,841
G
PYCARD
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:17,305,921...17,307,521
Ensembl chr 3:17,306,099...17,307,786
G
PYCR1
pyrroline-5-carboxylate reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:1,060,028...1,064,808
Ensembl chr12:1,060,570...1,064,805
G
R3HDM2
R3H domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:22,558,645...22,714,250
Ensembl chr 5:22,549,010...22,719,054
G
RAB30
RAB30, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:17,124,181...17,222,741
Ensembl chr 9:17,128,797...17,222,775
G
RAB31
RAB31, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:98,278,644...98,385,857
Ensembl chr 6:98,278,647...98,385,795
G
RAB32
RAB32, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:19,076,301...19,097,647
Ensembl chr 1:19,075,271...19,097,870
G
RAB40B
RAB40B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:492,298...516,965
Ensembl chr12:493,315...516,962
G
RAB8B
RAB8B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:108,772,851...108,840,222
Ensembl chr 1:108,772,851...108,840,227
G
RABGAP1L
RAB GTPase activating protein 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:116,402,395...117,060,057
Ensembl chr 9:116,463,779...117,060,053
G
RAC2
Rac family small GTPase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:10,553,986...10,571,082
Ensembl chr 5:10,553,433...10,573,014
G
RAMP1
receptor activity modifying protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:137,490,440...137,535,555
Ensembl chr15:137,490,356...137,535,553
G
RAMP2
receptor activity modifying protein 2
ISO
RGD
PMID:16713642
RGD:1625319
NCBI chr12:20,092,204...20,094,426
Ensembl chr12:20,092,196...20,094,469
G
RARRES1
retinoic acid receptor responder 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:98,461,307...98,506,552
Ensembl chr13:98,461,320...98,506,173
G
RASSF4
Ras association domain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:91,103,518...91,138,501
Ensembl chr14:91,103,526...91,125,360
G
RBL2
RB transcriptional corepressor like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:31,757,718...31,802,047
Ensembl chr 6:31,748,739...31,802,022
G
RBM3
RNA binding motif protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:42,704,019...42,707,587
Ensembl chr X:42,704,028...42,707,577
G
RBP4
retinol binding protein 4
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:17337499
RGD:329845879
NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765
G
RCN1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:28,696,528...28,714,083
Ensembl chr 2:28,696,661...28,709,672
G
RCN2
reticulocalbin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:57,040,872...57,058,277
Ensembl chr 7:57,041,003...57,059,330
G
RCSD1
RCSD domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:83,322,175...83,404,102
Ensembl chr 4:83,324,187...83,404,102
G
RDH10
retinol dehydrogenase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:62,569,877...62,600,981
Ensembl chr 4:62,569,885...62,601,439
G
RDH13
retinol dehydrogenase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr 6:59,274,383...59,293,139
Ensembl chr 6:59,274,387...59,292,765
G
RECK
reversion inducing cysteine rich protein with kazal motifs
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:236,821,243...236,898,280
Ensembl chr 1:236,821,414...236,898,276
G
REEP5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:116,845,681...116,886,361
Ensembl chr 2:116,845,571...116,886,358
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26806094
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RELL1
RELT like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:29,118,511...29,190,591
Ensembl chr 8:29,118,514...29,190,565
G
RELN
reelin
ISO
mRNA, protein:increased expression:liver, plasma (rat)
RGD
PMID:18449964
RGD:2317777
NCBI chr 9:103,460,855...103,963,728
Ensembl chr 9:103,460,863...103,963,883
G
RGN
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr X:41,725,660...41,749,736
Ensembl chr X:41,726,526...41,749,381
G
RGS10
regulator of G protein signaling 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:129,386,717...129,424,150
Ensembl chr14:129,381,208...129,423,702
G
RGS2
regulator of G protein signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr10:936,836...940,083
Ensembl chr10:936,789...940,098
G
RGS3
regulator of G protein signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:254,078,618...254,211,805
Ensembl chr 1:254,067,492...254,211,805
G
RGS5
regulator of G protein signaling 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:87,286,953...87,340,816
Ensembl chr 4:87,286,953...87,342,088
G
RHOA
ras homolog family member A
ISO
mRNA, protein:increased expression:liver
RGD
PMID:17596891
RGD:1642803
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
RHOQ
ras homolog family member Q
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:93,970,545...94,012,660
Ensembl chr 3:93,973,653...94,012,580
G
RIDA
reactive intermediate imine deaminase A homolog
treatment
ISO
RGD
PMID:23075396
RGD:9685568
NCBI chr 4:38,656,270...38,665,863
Ensembl chr 4:38,656,319...38,670,987
G
RIT1
Ras like without CAAX 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:94,117,721...94,127,882
Ensembl chr 4:94,117,882...94,127,384
G
RMDN2
regulator of microtubule dynamics 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:102,210,367...102,307,355
Ensembl chr 3:102,215,140...102,424,775
G
RMND5B
required for meiotic nuclear division 5 homolog B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:80,226,047...80,247,358
Ensembl chr 2:80,225,496...80,246,945
G
RNASE4
ribonuclease A family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 7:78,244,284...78,244,931
Ensembl chr 7:78,243,691...78,244,930
G
RNASEL
ribonuclease L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:123,895,045...123,910,386
Ensembl chr 9:123,893,294...123,910,398
G
RNF39
ring finger protein 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:22,637,732...22,642,427
Ensembl chr 7:22,636,904...22,642,612
G
ROBO2
roundabout guidance receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:177,365,712...179,040,027
Ensembl chr13:177,365,772...179,013,542
G
RPH3AL
rabphilin 3A like (without C2 domains)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr12:47,322,505...47,497,904
Ensembl chr12:47,388,582...47,497,902
G
RSRP1
arginine and serine rich protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:82,850,947...82,861,578
Ensembl chr 6:82,850,949...82,854,270
G
RTN4
reticulon 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:86,180,022...86,252,126
Ensembl chr 3:86,180,022...86,252,126
G
RTP3
receptor transporter protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:29,471,568...29,476,277
G
RXRA
retinoid X receptor alpha
ISO
RGD
PMID:15566521
RGD:1643114
NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
G
S100A10
S100 calcium binding protein A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:97,261,752...97,272,517
Ensembl chr 4:97,261,815...97,272,513
G
S100A11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:97,233,833...97,239,081
Ensembl chr 4:97,233,811...97,243,423
G
S100A6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:96,098,264...96,099,686
Ensembl chr 4:96,098,525...96,099,684
G
S100A9
S100 calcium binding protein A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:96,236,114...96,238,989
G
S1PR1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:117,064,632...117,069,724
Ensembl chr 4:117,064,755...117,069,650
G
SAMD11
sterile alpha motif domain containing 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:63,287,449...63,308,231
Ensembl chr 6:63,287,713...63,308,482
G
SASH3
SAM and SH3 domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:106,373,871...106,389,454
Ensembl chr X:106,373,954...106,389,444
G
SCD
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020
G
SDR42E1
short chain dehydrogenase/reductase family 42E, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:6,387,280...6,400,371
Ensembl chr 6:6,387,363...6,399,629
G
SDS
serine dehydratase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:38,503,922...38,513,908
Ensembl chr14:38,503,933...38,513,878
G
SELENOM
selenoprotein M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:47,902,862...47,905,350
Ensembl chr14:47,902,864...47,905,440
G
SELENOP
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:27,537,885...27,547,863
Ensembl chr16:27,537,885...27,631,130
G
SELENOW
selenoprotein W
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:53,470,563...53,474,662
Ensembl chr 6:53,470,787...53,474,652
G
SELP
selectin P
ISO
protein:increased expression:bone marrow
RGD
PMID:19333758
RGD:2312308
NCBI chr 4:81,376,804...81,401,240
Ensembl chr 4:81,365,740...81,399,955
G
SEMA6D
semaphorin 6D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:123,987,528...124,586,062
Ensembl chr 1:123,987,528...124,043,986
G
SENP2
SUMO specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr13:123,429,915...123,469,913
Ensembl chr13:123,429,995...123,471,926
G
SERPINA6
serpin family A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:115,535,552...115,554,536
Ensembl chr 7:115,535,697...115,554,570
G
SERPINA7
serpin family A member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:86,708,624...86,714,324
Ensembl chr X:86,708,632...86,714,329
G
SERPINB9
serpin peptidase inhibitor, clade B (ovalbumin), member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:1,723,302...1,732,562
Ensembl chr 7:1,721,383...1,735,074
G
SERPINC1
serpin family C member 1
treatment
ISO
associated with Inflammatory Bowel Diseases
RGD
PMID:16124052
RGD:1599330
NCBI chr 9:116,181,988...116,193,100
Ensembl chr 9:116,181,670...116,193,201
G
SERPINH1
serpin family H member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18376398 PMID:25380136
NCBI chr 9:9,782,939...9,794,485
Ensembl chr 9:9,783,042...9,794,483
G
SEZ6
seizure related 6 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:45,178,292...45,223,829
Ensembl chr12:45,178,313...45,203,216
G
SGCB
sarcoglycan beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:39,130,371...39,148,756
Ensembl chr 8:39,127,545...39,148,814
G
SGK2
serum/glucocorticoid regulated kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:46,188,160...46,208,807
Ensembl chr17:46,188,265...46,208,804
G
SH3BGRL3
SH3 domain binding glutamate rich protein like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:83,687,473...83,689,076
Ensembl chr 6:83,687,604...83,689,565
G
SHCBP1
SHC binding and spindle associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:38,029,869...38,063,773
Ensembl chr 6:38,029,864...38,063,859
G
SHISA3
shisa family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:33,373,633...33,379,039
Ensembl chr 8:33,374,265...33,378,951
G
SIGLEC5
sialic acid binding Ig like lectin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:58,365,066...58,387,138
G
SIRT1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26435214
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
G
SKAP2
src kinase associated phosphoprotein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:45,636,929...45,813,748
Ensembl chr18:45,637,360...45,790,259
G
SKIL
SKI like proto-oncogene
ISO
RGD
PMID:19189315
RGD:2308901
NCBI chr13:109,029,831...109,059,176
Ensembl chr13:109,029,952...109,059,173
G
SLA
Src like adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:8,166,829...8,247,396
Ensembl chr 4:8,189,232...8,247,388
G
SLA-7
MHC class I antigen 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:23,634,731...23,638,722
G
SLA-8
MHC class I antigen 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:23,622,352...23,625,818
G
SLA-DMA
SLA-DM alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:25,133,494...25,137,928
Ensembl chr 7:25,133,497...25,137,966
G
SLA-DMB
MHC class II, DM beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:25,119,278...25,125,089
Ensembl chr 7:25,119,282...25,128,236
G
SLA-DRA
MHC class II DR-alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:24,825,037...24,830,650
Ensembl chr 7:24,825,052...24,835,158
G
SLAMF9
SLAM family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:90,535,348...90,538,495
Ensembl chr 4:90,535,582...90,538,456
G
SLC10A1
solute carrier family 10 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 7:93,400,037...93,421,989
Ensembl chr 7:93,397,608...93,421,985
G
SLC12A3
solute carrier family 12 member 3
ISO
protein:altered expression:kidney (rat)
RGD
PMID:15956070
RGD:1580587
NCBI chr 6:18,844,752...18,885,497
Ensembl chr 6:18,844,600...18,885,476
G
SLC15A3
solute carrier family 15 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:10,799,927...10,814,363
Ensembl chr 2:10,800,503...10,814,389
G
SLC17A1
solute carrier family 17 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980 PMID:25380136
NCBI chr 7:20,522,650...20,589,037
Ensembl chr 7:20,523,022...20,574,460
G
SLC17A2
solute carrier family 17 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:20,596,547...20,663,498
Ensembl chr 7:20,644,244...20,663,423
G
SLC19A2
solute carrier family 19 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:81,510,221...81,535,099
Ensembl chr 4:81,510,098...81,536,464
G
SLC20A1
solute carrier family 20 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:43,844,716...43,860,547
Ensembl chr 3:43,844,722...43,860,547
G
SLC22A23
solute carrier family 22 member 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:1,988,690...2,131,778
Ensembl chr 7:1,988,696...2,131,908
G
SLC22A8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:8,782,030...8,800,998
Ensembl chr 2:8,782,060...8,800,997
G
SLC23A1
solute carrier family 23 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:141,258,318...141,277,555
Ensembl chr 2:141,258,323...141,276,442
G
SLC25A13
solute carrier family 25 member 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:75,781,421...75,980,606
Ensembl chr 9:75,781,361...75,980,518
G
SLC25A24
solute carrier family 25 member 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:111,580,186...111,632,390
Ensembl chr 4:111,579,663...111,634,266
G
SLC25A30
solute carrier family 25 member 30
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:21,848,242...21,872,781
Ensembl chr11:21,848,941...21,865,590
G
SLC25A4
solute carrier family 25 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:46,193,498...46,197,989
Ensembl chr15:46,193,746...46,200,987
G
SLC37A4
solute carrier family 37 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 9:46,247,278...46,254,068
Ensembl chr 9:46,247,282...46,254,031
G
SLC39A6
solute carrier family 39 member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:119,861,853...119,885,836
Ensembl chr 6:119,861,846...119,885,378
G
SLC39A8
solute carrier family 39 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:118,604,852...118,678,115
Ensembl chr 8:118,605,402...118,678,107
G
SLC43A2
solute carrier family 43 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:47,791,911...47,839,127
Ensembl chr12:47,791,913...47,839,012
G
SLC44A2
solute carrier family 44 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:69,364,946...69,399,081
Ensembl chr 2:69,365,012...69,399,081
G
SLC46A1
solute carrier family 46 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:44,677,499...44,686,277
Ensembl chr12:44,677,502...44,686,250
G
SLC4A4
solute carrier family 4 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:67,768,955...68,177,213
Ensembl chr 8:67,706,874...68,177,212
G
SLC66A3
solute carrier family 66 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:125,494,793...125,507,235
Ensembl chr 3:125,494,793...125,507,239
G
SLC7A1
solute carrier family 7 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:6,538,053...6,604,654
Ensembl chr11:6,538,045...6,604,658
G
SMAD1
SMAD family member 1
ISO
RGD
PMID:16447265
RGD:1643229
NCBI chr 8:82,907,557...82,987,909
Ensembl chr 8:82,908,527...82,968,994
G
SMAD2
SMAD family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16570350
NCBI chr 1:97,415,360...97,511,388
Ensembl chr 1:97,415,716...97,511,357
G
SMAD3
SMAD family member 3
treatment
ISO
RGD
PMID:25691930 PMID:30346985
RGD:151665755 RGD:401976485
NCBI chr 1:164,998,457...165,124,455
Ensembl chr 1:164,998,103...165,124,449
G
SMAD4
SMAD family member 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16570350 PMID:19824107
RGD:12903949
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
G
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:30,409,979...30,576,270
Ensembl chr13:30,409,983...30,576,327
G
SMC2
structural maintenance of chromosomes 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:245,409,559...245,459,032
Ensembl chr 1:245,410,147...245,475,929
G
SMC5
structural maintenance of chromosomes 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:223,560,271...223,653,370
G
SMOC1
SPARC related modular calcium binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:93,480,064...93,628,332
Ensembl chr 7:93,480,159...93,628,328
G
SMOC2
SPARC related modular calcium binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:1,193,163...1,332,739
Ensembl chr 1:1,193,167...1,332,694
G
SNAP23
synaptosome associated protein 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:128,849,465...128,888,972
Ensembl chr 1:128,847,931...128,888,947
G
SNAP29
synaptosome associated protein 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:50,492,187...50,511,475
Ensembl chr14:50,492,187...50,511,456
G
SNX7
sorting nexin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:119,040,986...119,258,507
Ensembl chr 4:119,035,133...119,255,877
G
SOAT1
sterol O-acyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:121,045,211...121,112,393
Ensembl chr 9:121,045,234...121,113,692
G
SOCS1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
SOX4
SRY-box transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:16,886,834...16,895,488
Ensembl chr 7:16,891,319...16,892,752
G
SP140
SP140 nuclear body protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:131,225,305...131,292,172
Ensembl chr15:131,226,626...131,292,170
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:liver, fat cell CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:8786698 PMID:18615449 PMID:25380136
RGD:2300030 RGD:2300071
NCBI chr16:71,368,164...71,380,972
Ensembl chr16:71,357,586...71,381,161
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:16221502
RGD:1581332
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SPSB4
splA/ryanodine receptor domain and SOCS box containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:81,849,908...81,926,764
Ensembl chr13:81,867,740...81,926,762
G
SPTAN1
spectrin alpha, non-erythrocytic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:268,936,120...269,002,261
Ensembl chr 1:268,936,025...269,002,256
G
SRD5A1
steroid 5 alpha-reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:75,309,830...75,335,438
Ensembl chr16:75,310,211...75,335,391
G
SREBF1
sterol regulatory element binding transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
G
SRGN
serglycin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:72,183,368...72,199,262
Ensembl chr14:72,183,363...72,199,250
G
SRI
sorcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:68,492,235...68,515,247
Ensembl chr 9:68,490,890...68,515,322
G
SRR
serine racemase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:48,386,915...48,407,917
Ensembl chr12:48,386,881...48,408,039
G
ST14
ST14 transmembrane serine protease matriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:56,888,246...56,929,771
Ensembl chr 9:56,888,246...56,929,767
G
STAC3
SH3 and cysteine rich domain 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:22,549,008...22,556,330
Ensembl chr 5:22,549,010...22,719,054
G
STARD13
StAR related lipid transfer domain containing 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:9,518,135...9,738,370
G
STAT3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STAT5A
signal transducer and activator of transcription 5A
treatment
ISO
RGD
PMID:30346985
RGD:151665755
NCBI chr12:20,474,221...20,498,785
Ensembl chr12:20,474,227...20,499,138
G
STAU2
staufen double-stranded RNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:62,139,456...62,455,509
Ensembl chr 4:62,139,464...62,455,499
G
STEAP4
STEAP4 metalloreductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:68,549,142...68,570,350
Ensembl chr 9:68,546,465...68,570,424
G
STK10
serine/threonine kinase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr16:52,003,768...52,140,378
Ensembl chr16:52,003,887...52,140,367
G
SULT1E1
sulfotransferase family 1E, estrogen-preferring, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 8:66,811,536...66,838,181
Ensembl chr 8:66,811,550...66,834,473
G
SULT2A1
sulfotransferase family 2A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17072980
NCBI chr 6:53,525,496...53,536,723
Ensembl chr 6:53,524,787...53,536,718
G
SYNRG
synergin gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:38,974,567...39,069,868
Ensembl chr12:38,975,916...39,069,798
G
TAGLN2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:90,566,272...90,574,762
G
TAP2
transporter 2, ATP binding cassette subfamily B member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,043,840...25,056,922
G
TAX1BP3
Tax1 binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:49,754,162...49,759,026
Ensembl chr12:49,754,166...49,759,412
G
TBC1D9
TBC1 domain family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:86,402,745...86,518,182
Ensembl chr 8:86,402,839...86,517,764
G
TCF20
transcription factor 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:6,430,217...6,534,948
Ensembl chr 5:6,484,365...6,528,172
G
TCF4
transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:104,718,809...105,079,919
Ensembl chr 1:104,719,151...105,079,919
G
TERT
telomerase reverse transcriptase
ISO
protein:increased expression, increased localization:nucleus
RGD
PMID:20353272
RGD:11038673
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TES
testin LIM domain protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:29,895,878...29,936,248
Ensembl chr18:29,895,882...29,936,233
G
TF
transferrin
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15650968 PMID:22464783
RGD:7244387
NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
G
TFEC
transcription factor EC
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:29,980,394...30,260,226
Ensembl chr18:30,122,494...30,175,484
G
TFPI2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:73,684,236...73,694,663
Ensembl chr 9:73,673,535...73,689,095
G
TGFB1
transforming growth factor beta 1
onset treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic associated with extrahepatic cholestasis protein:increased expression:liver associated with Chemical and Drug Induced Liver Injury mRNA:increased expression:liver (mouse)
CTD RGD
PMID:12586293 PMID:15772939 PMID:16009107 PMID:16579972 PMID:26806094 PMID:27528511 PMID:27605418 PMID:28390311 PMID:28465467 PMID:30092114 PMID:30243650 More...
RGD:14985231 RGD:14985232 RGD:14985234 RGD:14995475 RGD:1601595 RGD:39939037
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TGFB3
transforming growth factor beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:99,133,873...99,162,239
Ensembl chr 7:99,133,879...99,162,232
G
TGFBR1
transforming growth factor beta receptor 1
ISO
protein:increased expression:liver
RGD
PMID:15723089 PMID:16009107
RGD:1601595 RGD:2302027
NCBI chr 1:240,842,735...240,918,267
Ensembl chr 1:240,860,156...240,918,528
G
TGFBR2
transforming growth factor beta receptor 2
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:15942678 PMID:16627068 PMID:30346985
RGD:151665755 RGD:1579923
NCBI chr13:16,784,370...16,875,828
Ensembl chr13:16,784,490...16,878,160
G
TH
tyrosine hydroxylase
ISO
mRNA:decreased expression:superior mesenteric artery (rat)
RGD
PMID:18457899
RGD:5129683
NCBI chr 2:1,499,628...1,506,180
Ensembl chr 2:1,499,620...1,506,170
G
THBD
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:21112949 PMID:25380136
RGD:5685038
NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
G
THPO
thrombopoietin
ISO
mRNA:decreased expression:liver
RGD
PMID:9794189
RGD:1580082
NCBI chr13:122,259,654...122,267,860
Ensembl chr13:122,260,215...122,267,860
G
THYN1
thymocyte nuclear protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:60,802,925...60,807,404
Ensembl chr 9:60,802,928...60,807,409
G
TIAL1
TIA1 cytotoxic granule associated RNA binding protein like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:129,441,209...129,467,150
Ensembl chr14:129,441,211...129,467,112
G
TIMP1
TIMP metallopeptidase inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver
CTD RGD
PMID:8707259 PMID:16507762 PMID:16718785 PMID:16762003 PMID:21163135 PMID:25380136 More...
RGD:2290364
NCBI chr X:42,103,251...42,106,289
Ensembl chr X:42,102,172...42,106,296
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:3,254,794...3,300,835
Ensembl chr12:3,254,493...3,300,834
G
TKFC
triokinase and FMN cyclase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:10,158,183...10,171,452
Ensembl chr 2:10,158,188...10,171,449
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:22683883 PMID:27601294
RGD:18182936 RGD:7241092
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR3
toll like receptor 3
ISO
RGD
PMID:27178735
RGD:21079415
NCBI chr15:46,966,262...46,977,774
Ensembl chr15:46,969,006...46,979,291
G
TLR4
toll like receptor 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22683883 PMID:25380136 PMID:27601294
RGD:18182936 RGD:7241092
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TM6SF1
transmembrane 6 superfamily member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:51,815,109...51,844,938
Ensembl chr 7:51,815,530...51,845,163
G
TMBIM1
transmembrane BAX inhibitor motif containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:120,348,740...120,365,055
Ensembl chr15:120,348,735...120,365,007
G
TMEM106A
transmembrane protein 106A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:19,747,346...19,755,586
Ensembl chr12:19,745,782...19,755,521
G
TMEM165
transmembrane protein 165
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 8:54,751,570...54,796,352
Ensembl chr 8:54,751,572...54,787,886
G
TMEM178A
transmembrane protein 178A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:100,613,878...100,887,023
Ensembl chr 3:100,613,881...100,669,651
G
TMEM184B
transmembrane protein 184B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:9,633,554...9,682,116
Ensembl chr 5:9,633,554...9,682,115
G
TMEM43
transmembrane protein 43
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:70,397,069...70,417,213
Ensembl chr13:70,393,227...70,417,168
G
TMEM65
transmembrane protein 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:15,263,400...15,317,350
Ensembl chr 4:15,263,745...15,352,225
G
TMSB10
thymosin beta 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:59,776,236...59,777,252
Ensembl chr 3:59,776,236...59,777,252
G
TNF
tumor necrosis factor
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (mouse)
CTD RGD
PMID:16085334 PMID:24383550 PMID:28465467
RGD:10450610 RGD:39939037
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
G
TNFAIP8
TNF alpha induced protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:123,152,349...123,285,154
Ensembl chr 2:123,152,371...123,287,941
G
TNFRSF12A
TNF receptor superfamily member 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:39,166,288...39,168,294
Ensembl chr 3:39,166,298...39,168,302
G
TOR4A
torsin family 4 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
G
TPM1
tropomyosin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:108,986,981...109,016,090
Ensembl chr 1:108,986,986...109,020,035
G
TPM3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:95,542,329...95,572,946
Ensembl chr 4:95,542,473...95,572,938
G
TPM4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:61,453,721...61,476,781
Ensembl chr 2:61,453,725...61,476,781
G
TRAFD1
TRAF-type zinc finger domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:39,549,849...39,579,781
Ensembl chr14:39,549,851...39,579,781
G
TRAK2
trafficking kinesin protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:104,991,261...105,056,054
Ensembl chr15:104,991,726...105,055,025
G
TRIB3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:34,808,273...34,819,592
Ensembl chr17:34,807,582...34,816,451
G
TRIM24
tripartite motif containing 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:11,055,211...11,151,755
Ensembl chr18:11,055,213...11,151,404
G
TRIM59
tripartite motif containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:100,118,824...100,133,117
Ensembl chr13:100,118,826...100,132,967
G
TRPV1
transient receptor potential cation channel subfamily V member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17043671
NCBI chr12:49,676,536...49,709,634
Ensembl chr12:49,677,291...49,713,977
G
TSC22D1
TSC22 domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr11:22,518,792...22,634,411
Ensembl chr11:22,518,795...22,634,407
G
TSPAN8
tetraspanin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:35,210,744...35,482,788
Ensembl chr 5:35,240,715...35,321,845
G
TSPO
translocator protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 5:5,723,190...5,735,097
Ensembl chr 5:5,723,190...5,735,131
G
TSTD3
thiosulfate sulfurtransferase like domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:66,459,042...66,467,856
G
TTC36
tetratricopeptide repeat domain 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 9:45,829,014...45,838,978
Ensembl chr 9:45,829,191...45,838,979
G
TUBB6
tubulin beta 6 class V
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:97,233,639...97,240,692
Ensembl chr 6:97,229,868...97,240,662
G
TUSC3
tumor suppressor candidate 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:3,312,684...3,507,372
Ensembl chr17:3,312,741...3,507,729
G
TYROBP
transmembrane immune signaling adaptor TYROBP
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:45,309,199...45,312,562
Ensembl chr 6:45,309,201...45,312,539
G
U2SURP
U2 snRNP associated SURP domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:83,704,501...83,759,800
Ensembl chr13:83,704,587...83,759,971
G
UBD
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:22,501,130...22,502,883
Ensembl chr 7:22,500,601...22,515,602
G
UGCG
UDP-glucose ceramide glucosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:252,651,850...252,690,817
Ensembl chr 1:252,651,879...252,688,550
G
UNC5CL
unc-5 family C-terminal like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 7:36,332,183...36,347,409
Ensembl chr 7:36,332,201...36,347,175
G
UNC93B1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:4,898,414...4,909,833
Ensembl chr 2:4,898,409...4,909,856
G
VASP
vasodilator stimulated phosphoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:51,872,810...51,886,729
Ensembl chr 6:51,872,812...51,886,724
G
VAV1
vav guanine nucleotide exchange factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:72,327,433...72,391,649
Ensembl chr 2:72,326,716...72,391,648
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18416461 PMID:18458672
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VIM
vimentin
ISO
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)
CTD RGD
PMID:25380136 PMID:29323718
RGD:38599216
NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr13:26,036,610...26,073,168
Ensembl chr13:26,036,629...26,075,691
G
VOPP1
VOPP1 WW domain binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr18:48,607,923...48,693,858
Ensembl chr18:48,607,919...48,693,815
G
VSIR
V-set immunoregulatory receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr14:74,667,081...74,693,347
Ensembl chr14:74,666,624...74,693,281
G
VWF
von Willebrand factor
ISO
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:7531171 PMID:28527913
RGD:11079232
NCBI chr 5:64,516,627...64,655,938
Ensembl chr 5:64,517,555...64,655,938
G
WFDC2
WAP four-disulfide core domain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:47,816,452...47,824,087
Ensembl chr17:47,816,452...47,824,087
G
WIPF1
WAS/WASL interacting protein family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:80,521,032...80,646,462
G
WLS
Wnt ligand secretion mediator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 6:144,242,639...144,529,659
Ensembl chr 6:144,399,926...144,555,880
G
XPNPEP2
X-prolyl aminopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr X:106,333,785...106,363,412
Ensembl chr X:106,333,825...106,362,187
G
YBX1
Y-box binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16012952
NCBI chr 6:168,716,782...168,736,475
Ensembl chr 6:168,716,772...168,736,604
G
YPEL3
yippee like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:18,277,999...18,281,342
Ensembl chr 3:18,278,002...18,281,298
G
YWHAG
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 3:9,994,802...10,023,296
Ensembl chr 3:9,994,836...10,023,289
G
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 4:35,975,513...36,009,909
Ensembl chr 4:35,975,508...36,009,887
G
ZBTB4
zinc finger and BTB domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr12:52,759,912...52,775,725
G
ZDHHC13
zinc finger DHHC-type palmitoyltransferase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:40,251,511...40,310,455
Ensembl chr 2:40,251,246...40,310,455
G
ZDHHC2
zinc finger DHHC-type palmitoyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr17:4,855,129...4,928,109
Ensembl chr17:4,855,345...4,928,664
G
ZEB2
zinc finger E-box binding homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr15:7,498,879...7,631,347
Ensembl chr15:7,499,026...7,632,655
G
ZFP37
ZFP37 zinc finger protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 1:253,702,590...253,742,614
G
ZFYVE16
zinc finger FYVE-type containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25380136
NCBI chr 2:89,044,860...89,109,237
Ensembl chr 2:89,045,362...89,106,975
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all